{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:37:39Z","timestamp":1792633059397,"version":"4.5.0"},"reference-count":272,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100013030","name":"William and Ella Owens Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s12035-020-02023-z","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T18:02:38Z","timestamp":1595959358000},"page":"4373-4393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["The Role of Neurovascular System in Neurodegenerative Diseases"],"prefix":"10.1007","volume":"57","author":[{"given":"Ajmal","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanisha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4679-294X","authenticated-orcid":false,"given":"Mohammad Moshahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"2023_CR1","first-page":"39","volume":"61","author":"DJ Begley","year":"2003","unstructured":"Begley DJ, Brightman MW (2003) Structural and functional aspects of the blood-brain barrier. Prog Drug Res 61:39\u201378","journal-title":"Prog Drug Res"},{"issue":"12","key":"2023_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci 12(12):723\u2013738. https:\/\/doi.org\/10.1038\/nrn3114","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2023_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.devcel.2018.01.023","volume":"45","author":"I Paredes","year":"2018","unstructured":"Paredes I, Himmels P, Ruiz de Almodovar C (2018) Neurovascular communication during CNS development. Dev Cell 45(1):10\u201332. https:\/\/doi.org\/10.1016\/j.devcel.2018.01.023","journal-title":"Dev Cell"},{"issue":"11","key":"2023_CR4","doi-asserted-by":"publisher","first-page":"e48070","DOI":"10.15252\/embr.201948070","volume":"20","author":"U Lendahl","year":"2019","unstructured":"Lendahl U, Nilsson P, Betsholtz C (2019) Emerging links between cerebrovascular and neurodegenerative diseases-a special role for pericytes. EMBO Rep 20(11):e48070. https:\/\/doi.org\/10.15252\/embr.201948070","journal-title":"EMBO Rep"},{"issue":"21","key":"2023_CR5","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1111\/febs.13412","volume":"282","author":"J Keaney","year":"2015","unstructured":"Keaney J, Campbell M (2015) The dynamic blood-brain barrier. FEBS J 282(21):4067\u20134079. https:\/\/doi.org\/10.1111\/febs.13412","journal-title":"FEBS J"},{"issue":"5","key":"2023_CR6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","volume":"1862","author":"AR Nelson","year":"2016","unstructured":"Nelson AR, Sweeney MD, Sagare AP, Zlokovic BV (2016) Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer\u2019s disease. Biochim Biophys Acta 1862(5):887\u2013900. https:\/\/doi.org\/10.1016\/j.bbadis.2015.12.016","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2023_CR7","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"R Daneman","year":"2015","unstructured":"Daneman R, Prat A (2015) The blood-brain barrier. Cold Spring Harb Perspect Biol 7(1):a020412. https:\/\/doi.org\/10.1101\/cshperspect.a020412","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"2023_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12964-019-0340-8","volume":"17","author":"MH Geranmayeh","year":"2019","unstructured":"Geranmayeh MH, Rahbarghazi R, Farhoudi M (2019) Targeting pericytes for neurovascular regeneration. Cell Commun Signal 17(1):26. https:\/\/doi.org\/10.1186\/s12964-019-0340-8","journal-title":"Cell Commun Signal"},{"issue":"9","key":"2023_CR9","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.biocel.2011.05.002","volume":"43","author":"G Thanabalasundaram","year":"2011","unstructured":"Thanabalasundaram G, Schneidewind J, Pieper C, Galla HJ (2011) The impact of pericytes on the blood-brain barrier integrity depends critically on the pericyte differentiation stage. Int J Biochem Cell Biol 43(9):1284\u20131293. https:\/\/doi.org\/10.1016\/j.biocel.2011.05.002","journal-title":"Int J Biochem Cell Biol"},{"key":"2023_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fncel.2019.00282","volume":"13","author":"LS Brown","year":"2019","unstructured":"Brown LS, Foster CG, Courtney JM, King NE, Howells DW, Sutherland BA (2019) Pericytes and neurovascular function in the healthy and diseased brain. Front Cell Neurosci 13:282. https:\/\/doi.org\/10.3389\/fncel.2019.00282","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"2023_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nn.4288","volume":"19","author":"MD Sweeney","year":"2016","unstructured":"Sweeney MD, Ayyadurai S, Zlokovic BV (2016) Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci 19(6):771\u2013783. https:\/\/doi.org\/10.1038\/nn.4288","journal-title":"Nat Neurosci"},{"issue":"1","key":"2023_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12987-016-0040-3","volume":"13","author":"SB Hladky","year":"2016","unstructured":"Hladky SB, Barrand MA (2016) Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles. Fluids Barriers CNS 13(1):19. https:\/\/doi.org\/10.1186\/s12987-016-0040-3","journal-title":"Fluids Barriers CNS"},{"issue":"1 Suppl","key":"2023_CR13","doi-asserted-by":"publisher","first-page":"218S","DOI":"10.1093\/jn\/136.1.218S","volume":"136","author":"RA Hawkins","year":"2006","unstructured":"Hawkins RA, O'Kane RL, Simpson IA, Vina JR (2006) Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 136(1 Suppl):218S\u2013226S. https:\/\/doi.org\/10.1093\/jn\/136.1.218S","journal-title":"J Nutr"},{"issue":"2","key":"2023_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57(2):178\u2013201. https:\/\/doi.org\/10.1016\/j.neuron.2008.01.003","journal-title":"Neuron"},{"issue":"3","key":"2023_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1440-1819.1991.tb01187.x","volume":"45","author":"T Hashimura","year":"1991","unstructured":"Hashimura T, Kimura T, Miyakawa T (1991) Morphological changes of blood vessels in the brain with Alzheimer\u2019s disease. Jpn J Psychiatry Neurol 45(3):661\u2013665. https:\/\/doi.org\/10.1111\/j.1440-1819.1991.tb01187.x","journal-title":"Jpn J Psychiatry Neurol"},{"issue":"1","key":"2023_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"RD Bell","year":"2009","unstructured":"Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol 118(1):103\u2013113. https:\/\/doi.org\/10.1007\/s00401-009-0522-3","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2023_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","volume":"36","author":"MR Halliday","year":"2016","unstructured":"Halliday MR, Rege SV, Ma Q, Zhao Z, Miller CA, Winkler EA, Zlokovic BV (2016) Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. J Cereb Blood Flow Metab 36(1):216\u2013227. https:\/\/doi.org\/10.1038\/jcbfm.2015.44","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"2023_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2174\/156720507780362245","volume":"4","author":"R Deane","year":"2007","unstructured":"Deane R, Zlokovic BV (2007) Role of the blood-brain barrier in the pathogenesis of Alzheimer\u2019s disease. Curr Alzheimer Res 4(2):191\u2013197","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"2023_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1537-1891(02)00198-2","volume":"38","author":"JB Mackic","year":"2002","unstructured":"Mackic JB, Bading J, Ghiso J, Walker L, Wisniewski T, Frangione B, Zlokovic BV (2002) Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer\u2019s disease lesions. Vascul Pharmacol 38(6):303\u2013313","journal-title":"Vascul Pharmacol"},{"issue":"11","key":"2023_CR20","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406jem.20171406","volume":"214","author":"A Montagne","year":"2017","unstructured":"Montagne A, Zhao Z, Zlokovic BV (2017) Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction? J Exp Med 214(11):3151\u20133169. https:\/\/doi.org\/10.1084\/jem.20171406jem.20171406","journal-title":"J Exp Med"},{"issue":"3","key":"2023_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133\u2013150. https:\/\/doi.org\/10.1038\/nrneurol.2017.188","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"2023_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn.2017.48","volume":"18","author":"K Kisler","year":"2017","unstructured":"Kisler K, Nelson AR, Montagne A, Zlokovic BV (2017) Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci 18(7):419\u2013434. https:\/\/doi.org\/10.1038\/nrn.2017.48","journal-title":"Nat Rev Neurosci"},{"key":"2023_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.dadm.2017.10.001","volume":"9","author":"JF Leijenaar","year":"2017","unstructured":"Leijenaar JF, van Maurik IS, Kuijer JPA, van der Flier WM, Scheltens P, Barkhof F, Prins ND (2017) Lower cerebral blood flow in subjects with Alzheimer\u2019s dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging. Alzheimers Dement (Amst) 9:76\u201383. https:\/\/doi.org\/10.1016\/j.dadm.2017.10.001","journal-title":"Alzheimers Dement (Amst)"},{"key":"2023_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fnins.2020.00334","volume":"14","author":"X Yu","year":"2020","unstructured":"Yu X, Ji C, Shao A (2020) Neurovascular unit dysfunction and neurodegenerative disorders. Front Neurosci 14:334. https:\/\/doi.org\/10.3389\/fnins.2020.00334","journal-title":"Front Neurosci"},{"issue":"4","key":"2023_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nn.3966","volume":"18","author":"EA Winkler","year":"2015","unstructured":"Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S et al (2015) GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18(4):521\u2013530. https:\/\/doi.org\/10.1038\/nn.3966","journal-title":"Nat Neurosci"},{"issue":"5","key":"2023_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0197-4580(97)00111-5","volume":"18","author":"AD Mooradian","year":"1997","unstructured":"Mooradian AD, Chung HC, Shah GN (1997) GLUT-1 expression in the cerebra of patients with Alzheimer\u2019s disease. Neurobiol Aging 18(5):469\u2013474","journal-title":"Neurobiol Aging"},{"key":"2023_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fnagi.2018.00376","volume":"10","author":"F Wang","year":"2018","unstructured":"Wang F, Cao Y, Ma L, Pei H, Rausch WD, Li H (2018) Dysfunction of cerebrovascular endothelial cells: prelude to vascular dementia. Front Aging Neurosci 10:376. https:\/\/doi.org\/10.3389\/fnagi.2018.00376","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2023_CR28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1152\/physrev.00031.2008","volume":"89","author":"C Ruiz de Almodovar","year":"2009","unstructured":"Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P (2009) Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 89(2):607\u2013648. https:\/\/doi.org\/10.1152\/physrev.00031.2008","journal-title":"Physiol Rev"},{"issue":"8","key":"2023_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","volume":"12","author":"C Lange","year":"2016","unstructured":"Lange C, Storkebaum E, de Almodovar CR, Dewerchin M, Carmeliet P (2016) Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol 12(8):439\u2013454. https:\/\/doi.org\/10.1038\/nrneurol.2016.88","journal-title":"Nat Rev Neurol"},{"key":"2023_CR30","doi-asserted-by":"publisher","unstructured":"Govindpani K, McNamara LG, Smith NR, Vinnakota C, Waldvogel HJ, Faull RL, Kwakowsky A (2019) Vascular dysfunction in Alzheimer\u2019s disease: a prelude to the pathological process or a consequence of it? J Clin Med 8(5). https:\/\/doi.org\/10.3390\/jcm8050651","DOI":"10.3390\/jcm8050651"},{"issue":"1","key":"2023_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola C (2017) The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron 96(1):17\u201342. https:\/\/doi.org\/10.1016\/j.neuron.2017.07.030","journal-title":"Neuron"},{"key":"2023_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.expneurol.2017.01.013","volume":"291","author":"CF Lourenco","year":"2017","unstructured":"Lourenco CF, Ledo A, Barbosa RM, Laranjinha J (2017) Neurovascular uncoupling in the triple transgenic model of Alzheimer\u2019s disease: impaired cerebral blood flow response to neuronal-derived nitric oxide signaling. Exp Neurol 291:36\u201343. https:\/\/doi.org\/10.1016\/j.expneurol.2017.01.013","journal-title":"Exp Neurol"},{"issue":"3","key":"2023_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrn2336","volume":"9","author":"S Zacchigna","year":"2008","unstructured":"Zacchigna S, Lambrechts D, Carmeliet P (2008) Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci 9(3):169\u2013181. https:\/\/doi.org\/10.1038\/nrn2336","journal-title":"Nat Rev Neurosci"},{"key":"2023_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnagi.2020.00080","volume":"12","author":"MT Uemura","year":"2020","unstructured":"Uemura MT, Maki T, Ihara M, Lee VMY, Trojanowski JQ (2020) Brain microvascular pericytes in vascular cognitive impairment and dementia. Front Aging Neurosci 12:80. https:\/\/doi.org\/10.3389\/fnagi.2020.00080","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"2023_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/s0301-0082(00)00068-x","volume":"64","author":"E Farkas","year":"2001","unstructured":"Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging and Alzheimer\u2019s disease. Prog Neurobiol 64(6):575\u2013611. https:\/\/doi.org\/10.1016\/s0301-0082(00)00068-x","journal-title":"Prog Neurobiol"},{"key":"2023_CR36","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1038\/ncomms3932","volume":"4","author":"AP Sagare","year":"2013","unstructured":"Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A, Zlokovic BV (2013) Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun 4:2932. https:\/\/doi.org\/10.1038\/ncomms3932","journal-title":"Nat Commun"},{"issue":"3","key":"2023_CR37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nn.4489","volume":"20","author":"K Kisler","year":"2017","unstructured":"Kisler K, Nelson AR, Rege SV, Ramanathan A, Wang Y, Ahuja A, Lazic D, Tsai PS et al (2017) Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain. Nat Neurosci 20(3):406\u2013416. https:\/\/doi.org\/10.1038\/nn.4489","journal-title":"Nat Neurosci"},{"issue":"15","key":"2023_CR38","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","volume":"37","author":"CC Liu","year":"2017","unstructured":"Liu CC, Hu J, Zhao N, Wang J, Wang N, Cirrito JR, Kanekiyo T, Holtzman DM et al (2017) Astrocytic LRP1 mediates brain abeta clearance and impacts amyloid deposition. J Neurosci 37(15):4023\u20134031. https:\/\/doi.org\/10.1523\/JNEUROSCI.3442-16.2017","journal-title":"J Neurosci"},{"issue":"7","key":"2023_CR39","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1194\/jlr.R075796jlr.R075796","volume":"58","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, Tachibana M, Kanekiyo T, Bu G (2017) Role of LRP1 in the pathogenesis of Alzheimer\u2019s disease: evidence from clinical and preclinical studies. J Lipid Res 58(7):1267\u20131281. https:\/\/doi.org\/10.1194\/jlr.R075796jlr.R075796","journal-title":"J Lipid Res"},{"issue":"7","key":"2023_CR40","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","volume":"23","author":"C Tamaki","year":"2006","unstructured":"Tamaki C, Ohtsuki S, Iwatsubo T, Hashimoto T, Yamada K, Yabuki C, Terasaki T (2006) Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver. Pharm Res 23(7):1407\u20131416. https:\/\/doi.org\/10.1007\/s11095-006-0208-7","journal-title":"Pharm Res"},{"issue":"1","key":"2023_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-2010-1012481H1W2L372W21R482","volume":"24","author":"AP Sagare","year":"2011","unstructured":"Sagare AP, Deane R, Zetterberg H, Wallin A, Blennow K, Zlokovic BV (2011) Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-beta is an early biomarker for mild cognitive impairment preceding Alzheimer\u2019s disease. J Alzheimers Dis 24(1):25\u201334. https:\/\/doi.org\/10.3233\/JAD-2010-1012481H1W2L372W21R482","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"2023_CR42","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","volume":"17","author":"MK Rasmussen","year":"2018","unstructured":"Rasmussen MK, Mestre H, Nedergaard M (2018) The glymphatic pathway in neurological disorders. Lancet Neurol 17(11):1016\u20131024. https:\/\/doi.org\/10.1016\/S1474-4422(18)30318-1","journal-title":"Lancet Neurol"},{"key":"2023_CR43","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.3389\/fphar.2019.01656","volume":"10","author":"M Valenza","year":"2019","unstructured":"Valenza M, Facchinetti R, Steardo L, Scuderi C (2019) Altered waste disposal system in aging and Alzheimer\u2019s disease: focus on astrocytic aquaporin-4. Front Pharmacol 10:1656. https:\/\/doi.org\/10.3389\/fphar.2019.01656","journal-title":"Front Pharmacol"},{"issue":"147","key":"2023_CR44","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4(147):147ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748","journal-title":"Sci Transl Med"},{"issue":"1","key":"2023_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/jamaneurol.2016.4370","volume":"74","author":"DM Zeppenfeld","year":"2017","unstructured":"Zeppenfeld DM, Simon M, Haswell JD, D'Abreo D, Murchison C, Quinn JF, Grafe MR, Woltjer RL et al (2017) Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains. JAMA Neurol 74(1):91\u201399. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4370","journal-title":"JAMA Neurol"},{"issue":"10","key":"2023_CR46","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","volume":"21","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Kisler K, Montagne A, Toga AW, Zlokovic BV (2018) The role of brain vasculature in neurodegenerative disorders. Nat Neurosci 21(10):1318\u20131331. https:\/\/doi.org\/10.1038\/s41593-018-0234-x","journal-title":"Nat Neurosci"},{"issue":"2","key":"2023_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ana.20369","volume":"57","author":"R Kortekaas","year":"2005","unstructured":"Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH (2005) Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 57(2):176\u2013179. https:\/\/doi.org\/10.1002\/ana.20369","journal-title":"Ann Neurol"},{"issue":"8","key":"2023_CR48","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1007\/s00415-014-7403-y","volume":"261","author":"JH Ham","year":"2014","unstructured":"Ham JH, Yi H, Sunwoo MK, Hong JY, Sohn YH, Lee PH (2014) Cerebral microbleeds in patients with Parkinson\u2019s disease. J Neurol 261(8):1628\u20131635. https:\/\/doi.org\/10.1007\/s00415-014-7403-y","journal-title":"J Neurol"},{"issue":"Pt 3","key":"2023_CR49","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/brain\/awq377","volume":"134","author":"TR Melzer","year":"2011","unstructured":"Melzer TR, Watts R, MacAskill MR, Pearson JF, Rueger S, Pitcher TL, Livingston L, Graham C et al (2011) Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson\u2019s disease. Brain 134(Pt 3):845\u2013855. https:\/\/doi.org\/10.1093\/brain\/awq377","journal-title":"Brain"},{"issue":"3","key":"2023_CR50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3727\/000000007783464731","volume":"16","author":"BS Desai","year":"2007","unstructured":"Desai BS, Monahan AJ, Carvey PM, Hendey B (2007) Blood-brain barrier pathology in Alzheimer\u2019s and Parkinson\u2019s disease: implications for drug therapy. Cell Transplant 16(3):285\u2013299. https:\/\/doi.org\/10.3727\/000000007783464731","journal-title":"Cell Transplant"},{"issue":"6","key":"2023_CR51","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/j.1471-4159.2007.04567.x","volume":"101","author":"I Rite","year":"2007","unstructured":"Rite I, Machado A, Cano J, Venero JL (2007) Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. J Neurochem 101(6):1567\u20131582. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04567.x","journal-title":"J Neurochem"},{"issue":"1","key":"2023_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-019-0332-6","volume":"14","author":"A Masato","year":"2019","unstructured":"Masato A, Plotegher N, Boassa D, Bubacco L (2019) Impaired dopamine metabolism in Parkinson\u2019s disease pathogenesis. Mol Neurodegener 14(1):35. https:\/\/doi.org\/10.1186\/s13024-019-0332-6","journal-title":"Mol Neurodegener"},{"key":"2023_CR53","doi-asserted-by":"publisher","first-page":"175628641983835","DOI":"10.1177\/1756286419838354","volume":"12","author":"L Pelizzari","year":"2019","unstructured":"Pelizzari L, Lagana MM, Rossetto F, Bergsland N, Galli M, Baselli G, Clerici M, Nemni R et al (2019) Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson\u2019s disease. Ther Adv Neurol Disord 12:1756286419838354. https:\/\/doi.org\/10.1177\/1756286419838354","journal-title":"Ther Adv Neurol Disord"},{"key":"2023_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nicl.2014.07.014","volume":"6","author":"S Al-Bachari","year":"2014","unstructured":"Al-Bachari S, Parkes LM, Vidyasagar R, Hanby MF, Tharaken V, Leroi I, Emsley HC (2014) Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson\u2019s disease. Neuroimage Clin 6:1\u20138. https:\/\/doi.org\/10.1016\/j.nicl.2014.07.014","journal-title":"Neuroimage Clin"},{"issue":"5","key":"2023_CR55","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00702-017-1703-1","volume":"124","author":"ZJ Syrimi","year":"2017","unstructured":"Syrimi ZJ, Vojtisek L, Eliasova I, Viskova J, Svatkova A, Vanicek J, Rektorova I (2017) Arterial spin labelling detects posterior cortical hypoperfusion in non-demented patients with Parkinson\u2019s disease. J Neural Transm (Vienna) 124(5):551\u2013557. https:\/\/doi.org\/10.1007\/s00702-017-1703-1","journal-title":"J Neural Transm (Vienna)"},{"key":"2023_CR56","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.nbd.2014.12.006","volume":"74","author":"IS Pienaar","year":"2015","unstructured":"Pienaar IS, Lee CH, Elson JL, McGuinness L, Gentleman SM, Kalaria RN, Dexter DT (2015) Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson\u2019s disease. Neurobiol Dis 74:392\u2013405. https:\/\/doi.org\/10.1016\/j.nbd.2014.12.006","journal-title":"Neurobiol Dis"},{"key":"2023_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mvr.2019.03.005","volume":"124","author":"S Dohgu","year":"2019","unstructured":"Dohgu S, Takata F, Matsumoto J, Kimura I, Yamauchi A, Kataoka Y (2019) Monomeric alpha-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro. Microvasc Res 124:61\u201366. https:\/\/doi.org\/10.1016\/j.mvr.2019.03.005","journal-title":"Microvasc Res"},{"key":"2023_CR58","doi-asserted-by":"publisher","unstructured":"Gameiro M, Silva R, Rocha-Pereira C, Carmo H, Carvalho F, Bastos ML, Remiao F (2017) Cellular models and in vitro assays for the screening of modulators of P-gp, MRP1 and BCRP. Molecules 22(4). https:\/\/doi.org\/10.3390\/molecules22040600molecules22040600","DOI":"10.3390\/molecules22040600molecules22040600"},{"key":"2023_CR59","doi-asserted-by":"publisher","first-page":"7905486","DOI":"10.1155\/2017\/7905486","volume":"2017","author":"G Sita","year":"2017","unstructured":"Sita G, Hrelia P, Tarozzi A, Morroni F (2017) P-glycoprotein (ABCB1) and oxidative stress: focus on Alzheimer\u2019s disease. Oxid Med Cell Longev 2017:7905486. https:\/\/doi.org\/10.1155\/2017\/7905486","journal-title":"Oxid Med Cell Longev"},{"issue":"5\u20136","key":"2023_CR60","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00008877-200609000-00007","volume":"17","author":"GL Wenk","year":"2006","unstructured":"Wenk GL, Parsons CG, Danysz W (2006) Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine. Behav Pharmacol 17(5\u20136):411\u2013424","journal-title":"Behav Pharmacol"},{"key":"2023_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-019-0147-y","volume":"8","author":"W Zou","year":"2019","unstructured":"Zou W, Pu T, Feng W, Lu M, Zheng Y, Du R, Xiao M, Hu G (2019) Blocking meningeal lymphatic drainage aggravates Parkinson\u2019s disease-like pathology in mice overexpressing mutated alpha-synuclein. Transl Neurodegener 8:7. https:\/\/doi.org\/10.1186\/s40035-019-0147-y","journal-title":"Transl Neurodegener"},{"issue":"12","key":"2023_CR62","doi-asserted-by":"publisher","first-page":"21471","DOI":"10.1002\/jcp.28871","volume":"234","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Behnam M, Pourattar MA, Jafarpour H, Asemi Z (2019) Aquaporin 4: a key player in Parkinson\u2019s disease. J Cell Physiol 234(12):21471\u201321478. https:\/\/doi.org\/10.1002\/jcp.28871","journal-title":"J Cell Physiol"},{"key":"2023_CR63","doi-asserted-by":"publisher","unstructured":"Dong Y, Yuan Y, Fang Y, Zheng T, Du D, Gao D, Du J, Liu L et al (2020) Effect of aquaporin 4 protein overexpression in nigrostriatal system on development of Parkinson's disease. Int J Neurosci:1\u20138. https:\/\/doi.org\/10.1080\/00207454.2020.1753727","DOI":"10.1080\/00207454.2020.1753727"},{"issue":"5","key":"2023_CR64","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jnr.22594","volume":"89","author":"K Miyazaki","year":"2011","unstructured":"Miyazaki K, Ohta Y, Nagai M, Morimoto N, Kurata T, Takehisa Y, Ikeda Y, Matsuura T et al (2011) Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J Neurosci Res 89(5):718\u2013728. https:\/\/doi.org\/10.1002\/jnr.22594","journal-title":"J Neurosci Res"},{"issue":"4","key":"2023_CR65","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nn2073","volume":"11","author":"Z Zhong","year":"2008","unstructured":"Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, Stojanovic K, Sagare A et al (2008) ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11(4):420\u2013422. https:\/\/doi.org\/10.1038\/nn2073","journal-title":"Nat Neurosci"},{"key":"2023_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fncel.2014.00021","volume":"8","author":"S Garbuzova-Davis","year":"2014","unstructured":"Garbuzova-Davis S, Sanberg PR (2014) Blood-CNS Barrier Impairment in ALS patients versus an animal model. Front Cell Neurosci 8:21. https:\/\/doi.org\/10.3389\/fncel.2014.00021","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"2023_CR67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","volume":"125","author":"EA Winkler","year":"2013","unstructured":"Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH, Zlokovic BV (2013) Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol 125(1):111\u2013120. https:\/\/doi.org\/10.1007\/s00401-012-1039-8","journal-title":"Acta Neuropathol"},{"key":"2023_CR68","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-386986-9.00004-1","volume":"102","author":"MC Rodrigues","year":"2012","unstructured":"Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV, Sanberg PR, Voltarelli JC, Garbuzova-Davis S (2012) Neurovascular aspects of amyotrophic lateral sclerosis. Int Rev Neurobiol 102:91\u2013106. https:\/\/doi.org\/10.1016\/B978-0-12-386986-9.00004-1","journal-title":"Int Rev Neurobiol"},{"issue":"18","key":"2023_CR69","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1212\/WNL.0b013e3181a41228","volume":"72","author":"JS Henkel","year":"2009","unstructured":"Henkel JS, Beers DR, Wen S, Bowser R, Appel SH (2009) Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology 72(18):1614\u20131616. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a41228","journal-title":"Neurology"},{"issue":"11","key":"2023_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001205","volume":"2","author":"S Garbuzova-Davis","year":"2007","unstructured":"Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, Sanberg PR (2007) Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One 2(11):e1205. https:\/\/doi.org\/10.1371\/journal.pone.0001205","journal-title":"PLoS One"},{"key":"2023_CR71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainres.2011.04.049","volume":"1398","author":"S Garbuzova-Davis","year":"2011","unstructured":"Garbuzova-Davis S, Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV, Sanberg PR (2011) Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res 1398:113\u2013125. https:\/\/doi.org\/10.1016\/j.brainres.2011.04.049","journal-title":"Brain Res"},{"key":"2023_CR72","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","volume":"250","author":"CY Lin","year":"2013","unstructured":"Lin CY, Hsu YH, Lin MH, Yang TH, Chen HM, Chen YC, Hsiao HY, Chen CC et al (2013) Neurovascular abnormalities in humans and mice with Huntington\u2019s disease. Exp Neurol 250:20\u201330. https:\/\/doi.org\/10.1016\/j.expneurol.2013.08.019","journal-title":"Exp Neurol"},{"issue":"2","key":"2023_CR73","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.24406","volume":"78","author":"J Drouin-Ouellet","year":"2015","unstructured":"Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagace M, Kuan WL, Saint-Pierre M, Dury RJ, Alata W et al (2015) Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology. Ann Neurol 78(2):160\u2013177. https:\/\/doi.org\/10.1002\/ana.24406","journal-title":"Ann Neurol"},{"issue":"1","key":"2023_CR74","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","volume":"45","author":"S Franciosi","year":"2012","unstructured":"Franciosi S, Ryu JK, Shim Y, Hill A, Connolly C, Hayden MR, McLarnon JG, Leavitt BR (2012) Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease. Neurobiol Dis 45(1):438\u2013449. https:\/\/doi.org\/10.1016\/j.nbd.2011.09.003","journal-title":"Neurobiol Dis"},{"issue":"2","key":"2023_CR75","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuroimage.2011.08.112","volume":"59","author":"JJ Chen","year":"2012","unstructured":"Chen JJ, Salat DH, Rosas HD (2012) Complex relationships between cerebral blood flow and brain atrophy in early Huntington\u2019s disease. Neuroimage 59(2):1043\u20131051. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.08.112","journal-title":"Neuroimage"},{"issue":"2","key":"2023_CR76","first-page":"215","volume":"47","author":"A Ciarmiello","year":"2006","unstructured":"Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, Squitieri F (2006) Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease. J Nucl Med 47(2):215\u2013222","journal-title":"J Nucl Med"},{"issue":"12","key":"2023_CR77","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/s1357-4310(98)01371-9","volume":"4","author":"TC Andrews","year":"1998","unstructured":"Andrews TC, Brooks DJ (1998) Advances in the understanding of early Huntington\u2019s disease using the functional imaging techniques of PET and SPET. Mol Med Today 4(12):532\u2013539. https:\/\/doi.org\/10.1016\/s1357-4310(98)01371-9","journal-title":"Mol Med Today"},{"key":"2023_CR78","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.expneurol.2018.03.015","volume":"305","author":"T Padel","year":"2018","unstructured":"Padel T, Roth M, Gaceb A, Li JY, Bjorkqvist M, Paul G (2018) Brain pericyte activation occurs early in Huntington\u2019s disease. Exp Neurol 305:139\u2013150. https:\/\/doi.org\/10.1016\/j.expneurol.2018.03.015","journal-title":"Exp Neurol"},{"issue":"1","key":"2023_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1755-5949.2008.00068.x","volume":"15","author":"F Squitieri","year":"2009","unstructured":"Squitieri F, Cannella M, Simonelli M, Sassone J, Martino T, Venditti E, Ciammola A, Colonnese C et al (2009) Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington\u2019s disease. CNS Neurosci Ther 15(1):1\u201311. https:\/\/doi.org\/10.1111\/j.1755-5949.2008.00068.x","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"2023_CR80","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/ars.2009.2800","volume":"12","author":"Z Niatsetskaya","year":"2010","unstructured":"Niatsetskaya Z, Basso M, Speer RE, McConoughey SJ, Coppola G, Ma TC, Ratan RR (2010) HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington\u2019s disease and Alzheimer\u2019s disease. Antioxid Redox Signal 12(4):435\u2013443. https:\/\/doi.org\/10.1089\/ars.2009.2800","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2023_CR81","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/1567202610666131124234506","volume":"11","author":"S Sarkar","year":"2014","unstructured":"Sarkar S, Raymick J, Mann D, Bowyer JF, Hanig JP, Schmued LC, Paule MG, Chigurupati S (2014) Neurovascular changes in acute, sub-acute and chronic mouse models of Parkinson\u2019s disease. Curr Neurovasc Res 11(1):48\u201361. https:\/\/doi.org\/10.2174\/1567202610666131124234506","journal-title":"Curr Neurovasc Res"},{"issue":"5","key":"2023_CR82","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrn1106nrn1106","volume":"4","author":"EH Lo","year":"2003","unstructured":"Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4(5):399\u2013415. https:\/\/doi.org\/10.1038\/nrn1106nrn1106","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"2023_CR83","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s11481-013-9473-5","volume":"8","author":"F Dyrna","year":"2013","unstructured":"Dyrna F, Hanske S, Krueger M, Bechmann I (2013) The blood-brain barrier. J Neuroimmune Pharmacol 8(4):763\u2013773. https:\/\/doi.org\/10.1007\/s11481-013-9473-5","journal-title":"J Neuroimmune Pharmacol"},{"issue":"4","key":"2023_CR84","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/sj.mn.7800143","volume":"9","author":"RL Prewitt","year":"2002","unstructured":"Prewitt RL, Rice DC, Dobrian AD (2002) Adaptation of resistance arteries to increases in pressure. Microcirculation 9(4):295\u2013304. https:\/\/doi.org\/10.1038\/sj.mn.7800143","journal-title":"Microcirculation"},{"key":"2023_CR85","doi-asserted-by":"publisher","unstructured":"Huang L, Nakamura Y, Lo EH, Hayakawa K (2019) Astrocyte signaling in the neurovascular unit after central nervous system injury. Int J Mol Sci 20(2). https:\/\/doi.org\/10.3390\/ijms20020282","DOI":"10.3390\/ijms20020282"},{"issue":"12","key":"2023_CR86","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/nn.4428","volume":"19","author":"A Mishra","year":"2016","unstructured":"Mishra A, Reynolds JP, Chen Y, Gourine AV, Rusakov DA, Attwell D (2016) Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles. Nat Neurosci 19(12):1619\u20131627. https:\/\/doi.org\/10.1038\/nn.4428","journal-title":"Nat Neurosci"},{"issue":"1","key":"2023_CR87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1152\/physrev.1998.78.1.53","volume":"78","author":"FM Faraci","year":"1998","unstructured":"Faraci FM, Heistad DD (1998) Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78(1):53\u201397. https:\/\/doi.org\/10.1152\/physrev.1998.78.1.53","journal-title":"Physiol Rev"},{"issue":"3","key":"2023_CR88","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/str.33.3.661","volume":"33","author":"EM Golding","year":"2002","unstructured":"Golding EM, Marrelli SP, You J, Bryan RM Jr (2002) Endothelium-derived hyperpolarizing factor in the brain: a new regulator of cerebral blood flow? Stroke 33(3):661\u2013663","journal-title":"Stroke"},{"issue":"1","key":"2023_CR89","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0165-6147(02)00005-6","volume":"24","author":"R Busse","year":"2003","unstructured":"Busse R, Fleming I (2003) Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends Pharmacol Sci 24(1):24\u201329","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"2023_CR90","doi-asserted-by":"publisher","first-page":"H2177","DOI":"10.1152\/ajpheart.00605.2001283\/6\/H2177","volume":"283","author":"G Lagaud","year":"2002","unstructured":"Lagaud G, Karicheti V, Knot HJ, Christ GJ, Laher I (2002) Inhibitors of gap junctions attenuate myogenic tone in cerebral arteries. Am J Physiol Heart Circ Physiol 283(6):H2177\u2013H2186. https:\/\/doi.org\/10.1152\/ajpheart.00605.2001283\/6\/H2177","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Pt 3","key":"2023_CR91","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1113\/jphysiol.2003.047977jphysiol.2003.047977","volume":"551","author":"H Kawamura","year":"2003","unstructured":"Kawamura H, Sugiyama T, Wu DM, Kobayashi M, Yamanishi S, Katsumura K, Puro DG (2003) ATP: a vasoactive signal in the pericyte-containing microvasculature of the rat retina. J Physiol 551(Pt 3):787\u2013799. https:\/\/doi.org\/10.1113\/jphysiol.2003.047977jphysiol.2003.047977","journal-title":"J Physiol"},{"issue":"2","key":"2023_CR92","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12035-012-8244-2","volume":"45","author":"I Sa-Pereira","year":"2012","unstructured":"Sa-Pereira I, Brites D, Brito MA (2012) Neurovascular unit: a focus on pericytes. Mol Neurobiol 45(2):327\u2013347. https:\/\/doi.org\/10.1007\/s12035-012-8244-2","journal-title":"Mol Neurobiol"},{"issue":"7494","key":"2023_CR93","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature13165","volume":"508","author":"CN Hall","year":"2014","unstructured":"Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O'Farrell FM, Buchan AM et al (2014) Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508(7494):55\u201360. https:\/\/doi.org\/10.1038\/nature13165","journal-title":"Nature"},{"issue":"1","key":"2023_CR94","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/0271678X17719645","volume":"38","author":"A Gaceb","year":"2018","unstructured":"Gaceb A, Ozen I, Padel T, Barbariga M, Paul G (2018) Pericytes secrete pro-regenerative molecules in response to platelet-derived growth factor-BB. J Cereb Blood Flow Metab 38(1):45\u201357. https:\/\/doi.org\/10.1177\/0271678X17719645","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"2023_CR95","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1083\/jcb.153.3.543","volume":"153","author":"M Hellstrom","year":"2001","unstructured":"Hellstrom M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H, Betsholtz C (2001) Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153(3):543\u2013553. https:\/\/doi.org\/10.1083\/jcb.153.3.543","journal-title":"J Cell Biol"},{"issue":"5","key":"2023_CR96","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn1387nrn1387","volume":"5","author":"C Iadecola","year":"2004","unstructured":"Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease. Nat Rev Neurosci 5(5):347\u2013360. https:\/\/doi.org\/10.1038\/nrn1387nrn1387","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"2023_CR97","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.tins.2003.08.008","volume":"26","author":"M Nedergaard","year":"2003","unstructured":"Nedergaard M, Ransom B, Goldman SA (2003) New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26(10):523\u2013530. https:\/\/doi.org\/10.1016\/j.tins.2003.08.008","journal-title":"Trends Neurosci"},{"key":"2023_CR98","doi-asserted-by":"publisher","first-page":"823525","DOI":"10.1155\/2011\/823525","volume":"2011","author":"EC Peterson","year":"2011","unstructured":"Peterson EC, Wang Z, Britz G (2011) Regulation of cerebral blood flow. Int J Vasc Med 2011:823525. https:\/\/doi.org\/10.1155\/2011\/823525","journal-title":"Int J Vasc Med"},{"issue":"8","key":"2023_CR99","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/01.WCB.0000078322.96027.78","volume":"23","author":"GJ del Zoppo","year":"2003","unstructured":"del Zoppo GJ, Mabuchi T (2003) Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 23(8):879\u2013894. https:\/\/doi.org\/10.1097\/01.WCB.0000078322.96027.78","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"2023_CR100","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bandl.2006.08.002","volume":"102","author":"CT Drake","year":"2007","unstructured":"Drake CT, Iadecola C (2007) The role of neuronal signaling in controlling cerebral blood flow. Brain Lang 102(2):141\u2013152. https:\/\/doi.org\/10.1016\/j.bandl.2006.08.002","journal-title":"Brain Lang"},{"key":"2023_CR101","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnene.2010.00009","volume":"2","author":"B Cauli","year":"2010","unstructured":"Cauli B, Hamel E (2010) Revisiting the role of neurons in neurovascular coupling. Front Neuroenergetics 2:9. https:\/\/doi.org\/10.3389\/fnene.2010.00009","journal-title":"Front Neuroenergetics"},{"key":"2023_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnene.2011.00001","volume":"3","author":"D Kleinfeld","year":"2011","unstructured":"Kleinfeld D, Blinder P, Drew PJ, Driscoll JD, Muller A, Tsai PS, Shih AY (2011) A guide to delineate the logic of neurovascular signaling in the brain. Front Neuroenergetics 3:1. https:\/\/doi.org\/10.3389\/fnene.2011.00001","journal-title":"Front Neuroenergetics"},{"key":"2023_CR103","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.neuroimage.2017.12.070","volume":"169","author":"MC Murphy","year":"2018","unstructured":"Murphy MC, Chan KC, Kim SG, Vazquez AL (2018) Macroscale variation in resting-state neuronal activity and connectivity assessed by simultaneous calcium imaging, hemodynamic imaging and electrophysiology. Neuroimage 169:352\u2013362. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.12.070","journal-title":"Neuroimage"},{"key":"2023_CR104","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3389\/fnins.2019.01126","volume":"13","author":"X Zhang","year":"2019","unstructured":"Zhang X, Pan WJ, Keilholz S (2019) The relationship between local field potentials and the blood-oxygenation-level dependent MRI signal can be non-linear. Front Neurosci 13:1126. https:\/\/doi.org\/10.3389\/fnins.2019.01126","journal-title":"Front Neurosci"},{"issue":"12","key":"2023_CR105","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0166-2236(02)02264-6","volume":"25","author":"D Attwell","year":"2002","unstructured":"Attwell D, Iadecola C (2002) The neural basis of functional brain imaging signals. Trends Neurosci 25(12):621\u2013625","journal-title":"Trends Neurosci"},{"issue":"7\u20138","key":"2023_CR106","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/10408363.2017.1394267","volume":"54","author":"R Khaddaj Mallat","year":"2017","unstructured":"Khaddaj Mallat R, Mathew John C, Kendrick DJ, Braun AP (2017) The vascular endothelium: a regulator of arterial tone and interface for the immune system. Crit Rev Clin Lab Sci 54(7\u20138):458\u2013470. https:\/\/doi.org\/10.1080\/10408363.2017.1394267","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"2023_CR107","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1152\/japplphysiol.00937.2005","volume":"100","author":"J Andresen","year":"2006","unstructured":"Andresen J, Shafi NI, Bryan RM Jr (2006) Endothelial influences on cerebrovascular tone. J Appl Physiol (1985) 100(1):318\u2013327. https:\/\/doi.org\/10.1152\/japplphysiol.00937.2005","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"2023_CR108","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2015.11380171138017","volume":"4","author":"C Greene","year":"2016","unstructured":"Greene C, Campbell M (2016) Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers 4(1):e1138017. https:\/\/doi.org\/10.1080\/21688370.2015.11380171138017","journal-title":"Tissue Barriers"},{"issue":"2","key":"2023_CR109","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cvr\/cvt084cvt084","volume":"99","author":"J Ando","year":"2013","unstructured":"Ando J, Yamamoto K (2013) Flow detection and calcium signalling in vascular endothelial cells. Cardiovasc Res 99(2):260\u2013268. https:\/\/doi.org\/10.1093\/cvr\/cvt084cvt084","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2023_CR110","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41598-018-37367-z","volume":"9","author":"T Galochkina","year":"2019","unstructured":"Galochkina T, Ng Fuk Chong M, Challali L, Abbar S, Etchebest C (2019) New insights into GluT1 mechanics during glucose transfer. Sci Rep 9(1):998. https:\/\/doi.org\/10.1038\/s41598-018-37367-z","journal-title":"Sci Rep"},{"issue":"9","key":"2023_CR111","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s11095-007-9374-5","volume":"24","author":"S Ohtsuki","year":"2007","unstructured":"Ohtsuki S, Terasaki T (2007) Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm Res 24(9):1745\u20131758. https:\/\/doi.org\/10.1007\/s11095-007-9374-5","journal-title":"Pharm Res"},{"issue":"11","key":"2023_CR112","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/sj.jcbfm.9600521","volume":"27","author":"IA Simpson","year":"2007","unstructured":"Simpson IA, Carruthers A, Vannucci SJ (2007) Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab 27(11):1766\u20131791. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600521","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"2023_CR113","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-06-2854","volume":"13","author":"JF Deeken","year":"2007","unstructured":"Deeken JF, Loscher W (2007) The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clin Cancer Res 13(6):1663\u20131674. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2854","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2023_CR114","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1471-4159.2007.04773.x","volume":"103","author":"R Spector","year":"2007","unstructured":"Spector R, Johanson CE (2007) Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E. J Neurochem 103(2):425\u2013438. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04773.x","journal-title":"J Neurochem"},{"key":"2023_CR115","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.acr.2014.10.002","volume":"125","author":"DS Miller","year":"2015","unstructured":"Miller DS (2015) Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly. Adv Cancer Res 125:43\u201370. https:\/\/doi.org\/10.1016\/bs.acr.2014.10.002","journal-title":"Adv Cancer Res"},{"issue":"3","key":"2023_CR116","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tips.2007.01.007","volume":"28","author":"DM Hermann","year":"2007","unstructured":"Hermann DM, Bassetti CL (2007) Implications of ATP-binding cassette transporters for brain pharmacotherapies. Trends Pharmacol Sci 28(3):128\u2013134. https:\/\/doi.org\/10.1016\/j.tips.2007.01.007","journal-title":"Trends Pharmacol Sci"},{"key":"2023_CR117","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fnagi.2019.00196","volume":"11","author":"F Erdo","year":"2019","unstructured":"Erdo F, Krajcsi P (2019) Age-related functional and expressional changes in efflux pathways at the blood-brain barrier. Front Aging Neurosci 11:196. https:\/\/doi.org\/10.3389\/fnagi.2019.00196","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2023_CR118","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrn2995nrn2995","volume":"12","author":"EA Neuwelt","year":"2011","unstructured":"Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, Leybaert L, Molnar Z et al (2011) Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 12(3):169\u2013182. https:\/\/doi.org\/10.1038\/nrn2995nrn2995","journal-title":"Nat Rev Neurosci"},{"issue":"7321","key":"2023_CR119","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature09613","volume":"468","author":"D Attwell","year":"2010","unstructured":"Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA (2010) Glial and neuronal control of brain blood flow. Nature 468(7321):232\u2013243. https:\/\/doi.org\/10.1038\/nature09613","journal-title":"Nature"},{"key":"2023_CR120","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/3-540-64753-8_5","volume":"134","author":"AP Somlyo","year":"1999","unstructured":"Somlyo AP, Wu X, Walker LA, Somlyo AV (1999) Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol 134:201\u2013234. https:\/\/doi.org\/10.1007\/3-540-64753-8_5","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"7070","key":"2023_CR121","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nature04481","volume":"438","author":"DA Greenberg","year":"2005","unstructured":"Greenberg DA, Jin K (2005) From angiogenesis to neuropathology. Nature 438(7070):954\u2013959. https:\/\/doi.org\/10.1038\/nature04481","journal-title":"Nature"},{"issue":"10","key":"2023_CR122","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.molmed.2009.08.005","volume":"15","author":"I Segura","year":"2009","unstructured":"Segura I, De Smet F, Hohensinner PJ, Ruiz de Almodovar C, Carmeliet P (2009) The neurovascular link in health and disease: an update. Trends Mol Med 15(10):439\u2013451. https:\/\/doi.org\/10.1016\/j.molmed.2009.08.005","journal-title":"Trends Mol Med"},{"key":"2023_CR123","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677\u2013736. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.677","journal-title":"Annu Rev Neurosci"},{"key":"2023_CR124","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.brainres.2015.02.042","volume":"1623","author":"L Ruan","year":"2015","unstructured":"Ruan L, Wang B, ZhuGe Q, Jin K (2015) Coupling of neurogenesis and angiogenesis after ischemic stroke. Brain Res 1623:166\u2013173. https:\/\/doi.org\/10.1016\/j.brainres.2015.02.042","journal-title":"Brain Res"},{"issue":"13","key":"2023_CR125","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1523\/JNEUROSCI.4956-08.200929\/13\/4172","volume":"29","author":"M Snapyan","year":"2009","unstructured":"Snapyan M, Lemasson M, Brill MS, Blais M, Massouh M, Ninkovic J, Gravel C, Berthod F et al (2009) Vasculature guides migrating neuronal precursors in the adult mammalian forebrain via brain-derived neurotrophic factor signaling. J Neurosci 29(13):4172\u20134188. https:\/\/doi.org\/10.1523\/JNEUROSCI.4956-08.200929\/13\/4172","journal-title":"J Neurosci"},{"key":"2023_CR126","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fnmol.2019.00085","volume":"12","author":"A Karakatsani","year":"2019","unstructured":"Karakatsani A, Shah B, Ruiz de Almodovar C (2019) Blood vessels as regulators of neural stem cell properties. Front Mol Neurosci 12:85. https:\/\/doi.org\/10.3389\/fnmol.2019.00085","journal-title":"Front Mol Neurosci"},{"issue":"5675","key":"2023_CR127","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1126\/science.10955051095505","volume":"304","author":"Q Shen","year":"2004","unstructured":"Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, Vincent P, Pumiglia K et al (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304(5675):1338\u20131340. https:\/\/doi.org\/10.1126\/science.10955051095505","journal-title":"Science"},{"key":"2023_CR128","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fncel.2018.00323","volume":"12","author":"Z Szepesi","year":"2018","unstructured":"Szepesi Z, Manouchehrian O, Bachiller S, Deierborg T (2018) Bidirectional microglia-neuron communication in health and disease. Front Cell Neurosci 12:323. https:\/\/doi.org\/10.3389\/fncel.2018.00323","journal-title":"Front Cell Neurosci"},{"issue":"33","key":"2023_CR129","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.1523\/JNEUROSCI.2010-08.200828\/33\/8294","volume":"28","author":"JC Dugas","year":"2008","unstructured":"Dugas JC, Mandemakers W, Rogers M, Ibrahim A, Daneman R, Barres BA (2008) A novel purification method for CNS projection neurons leads to the identification of brain vascular cells as a source of trophic support for corticospinal motor neurons. J Neurosci 28(33):8294\u20138305. https:\/\/doi.org\/10.1523\/JNEUROSCI.2010-08.200828\/33\/8294","journal-title":"J Neurosci"},{"issue":"21","key":"2023_CR130","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1073\/pnas.08011051050801105105","volume":"105","author":"S Guo","year":"2008","unstructured":"Guo S, Kim WJ, Lok J, Lee SR, Besancon E, Luo BH, Stins MF, Wang X et al (2008) Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc Natl Acad Sci U S A 105(21):7582\u20137587. https:\/\/doi.org\/10.1073\/pnas.08011051050801105105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023_CR131","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fncel.2018.00085","volume":"12","author":"M Abbasi","year":"2018","unstructured":"Abbasi M, Gupta V, Chitranshi N, You Y, Dheer Y, Mirzaei M, Graham SL (2018) Regulation of brain-derived neurotrophic factor and growth factor signaling pathways by tyrosine phosphatase Shp2 in the retina: a brief review. Front Cell Neurosci 12:85. https:\/\/doi.org\/10.3389\/fncel.2018.00085","journal-title":"Front Cell Neurosci"},{"issue":"14","key":"2023_CR132","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1523\/JNEUROSCI.0035-09.200929\/14\/4351","volume":"29","author":"K Arai","year":"2009","unstructured":"Arai K, Lo EH (2009) An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J Neurosci 29(14):4351\u20134355. https:\/\/doi.org\/10.1523\/JNEUROSCI.0035-09.200929\/14\/4351","journal-title":"J Neurosci"},{"issue":"1","key":"2023_CR133","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12974-018-1189-2","volume":"15","author":"C Xing","year":"2018","unstructured":"Xing C, Li W, Deng W, Ning M, Lo EH (2018) A potential gliovascular mechanism for microglial activation: differential phenotypic switching of microglia by endothelium versus astrocytes. J Neuroinflammation 15(1):143. https:\/\/doi.org\/10.1186\/s12974-018-1189-2","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2023_CR134","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00441-008-0658-9","volume":"335","author":"H Wolburg","year":"2009","unstructured":"Wolburg H, Noell S, Mack A, Wolburg-Buchholz K, Fallier-Becker P (2009) Brain endothelial cells and the glio-vascular complex. Cell Tissue Res 335(1):75\u201396. https:\/\/doi.org\/10.1007\/s00441-008-0658-9","journal-title":"Cell Tissue Res"},{"issue":"19","key":"2023_CR135","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1073\/pnas.11211461091121146109","volume":"109","author":"K Hayakawa","year":"2012","unstructured":"Hayakawa K, Pham LD, Katusic ZS, Arai K, Lo EH (2012) Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc Natl Acad Sci U S A 109(19):7505\u20137510. https:\/\/doi.org\/10.1073\/pnas.11211461091121146109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2023_CR136","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1023\/b:cemn.0000022776.47302.ce","volume":"24","author":"S Dohgu","year":"2004","unstructured":"Dohgu S, Yamauchi A, Takata F, Naito M, Tsuruo T, Higuchi S, Sawada Y, Kataoka Y (2004) Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells. Cell Mol Neurobiol 24(3):491\u2013497. https:\/\/doi.org\/10.1023\/b:cemn.0000022776.47302.ce","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"2023_CR137","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.neuron.2011.01.023","volume":"69","author":"MK Lehtinen","year":"2011","unstructured":"Lehtinen MK, Zappaterra MW, Chen X, Yang YJ, Hill AD, Lun M, Maynard T, Gonzalez D et al (2011) The cerebrospinal fluid provides a proliferative niche for neural progenitor cells. Neuron 69(5):893\u2013905. https:\/\/doi.org\/10.1016\/j.neuron.2011.01.023","journal-title":"Neuron"},{"key":"2023_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-6448-2_1","volume":"1493","author":"LT Alto","year":"2017","unstructured":"Alto LT, Terman JR (2017) Semaphorins and their signaling mechanisms. Methods Mol Biol 1493:1\u201325. https:\/\/doi.org\/10.1007\/978-1-4939-6448-2_1","journal-title":"Methods Mol Biol"},{"issue":"7347","key":"2023_CR139","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298\u2013307. https:\/\/doi.org\/10.1038\/nature10144nature10144","journal-title":"Nature"},{"issue":"5","key":"2023_CR140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217216PONE-D-18-36131","volume":"14","author":"P Majerova","year":"2019","unstructured":"Majerova P, Michalicova A, Cente M, Hanes J, Vegh J, Kittel A, Kosikova N, Cigankova V et al (2019) Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies. PLoS One 14(5):e0217216. https:\/\/doi.org\/10.1371\/journal.pone.0217216PONE-D-18-36131","journal-title":"PLoS One"},{"issue":"6","key":"2023_CR141","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/jnen\/62.6.593","volume":"62","author":"JS Pachter","year":"2003","unstructured":"Pachter JS, de Vries HE, Fabry Z (2003) The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 62(6):593\u2013604","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"2023_CR142","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s40263-017-0483-3","volume":"31","author":"A Ardura-Fabregat","year":"2017","unstructured":"Ardura-Fabregat A, Boddeke E, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyzeriat K, Dansokho C, Dierkes T et al (2017) Targeting neuroinflammation to treat Alzheimer\u2019s disease. CNS Drugs 31(12):1057\u20131082. https:\/\/doi.org\/10.1007\/s40263-017-0483-3","journal-title":"CNS Drugs"},{"issue":"2","key":"2023_CR143","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuron.2013.04.005","volume":"78","author":"A Lampron","year":"2013","unstructured":"Lampron A, Elali A, Rivest S (2013) Innate immunity in the CNS: redefining the relationship between the CNS and Its environment. Neuron 78(2):214\u2013232. https:\/\/doi.org\/10.1016\/j.neuron.2013.04.005","journal-title":"Neuron"},{"issue":"12","key":"2023_CR144","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1073\/pnas.10154131081015413108","volume":"108","author":"L Park","year":"2011","unstructured":"Park L, Wang G, Zhou P, Zhou J, Pitstick R, Previti ML, Younkin L, Younkin SG et al (2011) Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta. Proc Natl Acad Sci U S A 108(12):5063\u20135068. https:\/\/doi.org\/10.1073\/pnas.10154131081015413108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2023_CR145","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","volume":"28","author":"I Galea","year":"2007","unstructured":"Galea I, Bechmann I, Perry VH (2007) What is immune privilege (not)? Trends Immunol 28(1):12\u201318. https:\/\/doi.org\/10.1016\/j.it.2006.11.004","journal-title":"Trends Immunol"},{"issue":"10","key":"2023_CR146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222721PONE-D-19-12923","volume":"14","author":"K Mietani","year":"2019","unstructured":"Mietani K, Sumitani M, Ogata T, Shimojo N, Inoue R, Abe H, Kawamura G, Yamada Y (2019) Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit. PLoS One 14(10):e0222721. https:\/\/doi.org\/10.1371\/journal.pone.0222721PONE-D-19-12923","journal-title":"PLoS One"},{"key":"2023_CR147","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519\u2013550. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132612","journal-title":"Annu Rev Immunol"},{"key":"2023_CR148","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fncel.2019.00337","volume":"13","author":"SF Spampinato","year":"2019","unstructured":"Spampinato SF, Merlo S, Fagone E, Fruciano M, Barbagallo C, Kanda T, Sano Y, Purrello M et al (2019) Astrocytes modify migration of PBMCs induced by beta-amyloid in a blood-brain barrier in vitro model. Front Cell Neurosci 13:337. https:\/\/doi.org\/10.3389\/fncel.2019.00337","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"2023_CR149","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.4049\/jimmunol.165.6.3375","volume":"165","author":"S Etienne-Manneville","year":"2000","unstructured":"Etienne-Manneville S, Manneville JB, Adamson P, Wilbourn B, Greenwood J, Couraud PO (2000) ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J Immunol 165(6):3375\u20133383","journal-title":"J Immunol"},{"issue":"13","key":"2023_CR150","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2217\/nnm-2018-0139","volume":"13","author":"V Cena","year":"2018","unstructured":"Cena V, Jativa P (2018) Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases. Nanomedicine (Lond) 13(13):1513\u20131516. https:\/\/doi.org\/10.2217\/nnm-2018-0139","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"2023_CR151","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1600-065X.2012.01127.x","volume":"248","author":"Y Takeshita","year":"2012","unstructured":"Takeshita Y, Ransohoff RM (2012) Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol Rev 248(1):228\u2013239. https:\/\/doi.org\/10.1111\/j.1600-065X.2012.01127.x","journal-title":"Immunol Rev"},{"issue":"7","key":"2023_CR152","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17(7):796\u2013808. https:\/\/doi.org\/10.1038\/nm.2399nm.2399","journal-title":"Nat Med"},{"key":"2023_CR153","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.3389\/fimmu.2019.02066","volume":"10","author":"R Wesselingh","year":"2019","unstructured":"Wesselingh R, Butzkueven H, Buzzard K, Tarlinton D, O'Brien TJ, Monif M (2019) Innate immunity in the central nervous system: a missing piece of the autoimmune encephalitis puzzle? Front Immunol 10:2066. https:\/\/doi.org\/10.3389\/fimmu.2019.02066","journal-title":"Front Immunol"},{"issue":"7","key":"2023_CR154","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.4049\/jimmunol.161.7.3767","volume":"161","author":"EH Tran","year":"1998","unstructured":"Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T (1998) Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 161(7):3767\u20133775","journal-title":"J Immunol"},{"issue":"4","key":"2023_CR155","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1172\/JCI5864858648","volume":"122","author":"DC Wraith","year":"2012","unstructured":"Wraith DC, Nicholson LB (2012) The adaptive immune system in diseases of the central nervous system. J Clin Invest 122(4):1172\u20131179. https:\/\/doi.org\/10.1172\/JCI5864858648","journal-title":"J Clin Invest"},{"issue":"1","key":"2023_CR156","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S","volume":"27","author":"I Bechmann","year":"1999","unstructured":"Bechmann I, Mor G, Nilsen J, Eliza M, Nitsch R, Naftolin F (1999) FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Glia 27(1):62\u201374. https:\/\/doi.org\/10.1002\/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S","journal-title":"Glia"},{"issue":"5","key":"2023_CR157","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/0963689718779345","volume":"27","author":"JX Yang","year":"2018","unstructured":"Yang JX, Pan YY, Wang XX, Qiu YG, Mao W (2018) Endothelial progenitor cells in age-related vascular remodeling. Cell Transplant 27(5):786\u2013795. https:\/\/doi.org\/10.1177\/0963689718779345","journal-title":"Cell Transplant"},{"issue":"7","key":"2023_CR158","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1056\/NEJMoa022287348\/7\/593","volume":"348","author":"JM Hill","year":"2003","unstructured":"Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348(7):593\u2013600. https:\/\/doi.org\/10.1056\/NEJMoa022287348\/7\/593","journal-title":"N Engl J Med"},{"issue":"12","key":"2023_CR159","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","volume":"40","author":"NA Jessen","year":"2015","unstructured":"Jessen NA, Munk AS, Lundgaard I, Nedergaard M (2015) The glymphatic system: a beginner\u2019s guide. Neurochem Res 40(12):2583\u20132599. https:\/\/doi.org\/10.1007\/s11064-015-1581-6","journal-title":"Neurochem Res"},{"key":"2023_CR160","doi-asserted-by":"publisher","unstructured":"Mestre H, Mori Y, Nedergaard M (2020) The brain\u2019s glymphatic system: current controversies. Trends Neurosci. https:\/\/doi.org\/10.1016\/j.tins.2020.04.003","DOI":"10.1016\/j.tins.2020.04.003"},{"issue":"8","key":"2023_CR161","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H et al (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11(8):457\u2013470. https:\/\/doi.org\/10.1038\/nrneurol.2015.119","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2023_CR162","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000490349","volume":"65","author":"H Benveniste","year":"2019","unstructured":"Benveniste H, Liu X, Koundal S, Sanggaard S, Lee H, Wardlaw J (2019) The glymphatic system and waste clearance with brain aging: a review. Gerontology 65(2):106\u2013119. https:\/\/doi.org\/10.1159\/000490349","journal-title":"Gerontology"},{"key":"2023_CR163","doi-asserted-by":"publisher","unstructured":"Levit A, Hachinski V, Whitehead SN (2020) Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease. Geroscience. https:\/\/doi.org\/10.1007\/s11357-020-00164-6","DOI":"10.1007\/s11357-020-00164-6"},{"issue":"5","key":"2023_CR164","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.mehy.2013.09.012","volume":"81","author":"M Franzblau","year":"2013","unstructured":"Franzblau M, Gonzales-Portillo C, Gonzales-Portillo GS, Diamandis T, Borlongan MC, Tajiri N, Borlongan CV (2013) Vascular damage: a persisting pathology common to Alzheimer\u2019s disease and traumatic brain injury. Med Hypotheses 81(5):842\u2013845. https:\/\/doi.org\/10.1016\/j.mehy.2013.09.012","journal-title":"Med Hypotheses"},{"issue":"4","key":"2023_CR165","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10456-017-9568-3","volume":"20","author":"P Kelly","year":"2017","unstructured":"Kelly P, Denver P, Satchell SC, Ackermann M, Konerding MA, Mitchell CA (2017) Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe\/PS1dE9 model of Alzheimer\u2019s disease. Angiogenesis 20(4):567\u2013580. https:\/\/doi.org\/10.1007\/s10456-017-9568-3","journal-title":"Angiogenesis"},{"issue":"5","key":"2023_CR166","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jalz.2016.08.013","volume":"13","author":"AE Leeuwis","year":"2017","unstructured":"Leeuwis AE, Benedictus MR, Kuijer JPA, Binnewijzend MAA, Hooghiemstra AM, Verfaillie SCJ, Koene T, Scheltens P et al (2017) Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer\u2019s disease. Alzheimers Dement 13(5):531\u2013540. https:\/\/doi.org\/10.1016\/j.jalz.2016.08.013","journal-title":"Alzheimers Dement"},{"key":"2023_CR167","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fneur.2019.00154","volume":"10","author":"ME Haque","year":"2019","unstructured":"Haque ME, Gabr RE, Hasan KM, George S, Arevalo OD, Zha A, Alderman S, Jeevarajan J et al (2019) Ongoing secondary degeneration of the limbic system in patients with ischemic stroke: a longitudinal MRI study. Front Neurol 10:154. https:\/\/doi.org\/10.3389\/fneur.2019.00154","journal-title":"Front Neurol"},{"issue":"4","key":"2023_CR168","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/jcbfm.1991.121","volume":"11","author":"AJ Martin","year":"1991","unstructured":"Martin AJ, Friston KJ, Colebatch JG, Frackowiak RS (1991) Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab 11(4):684\u2013689. https:\/\/doi.org\/10.1038\/jcbfm.1991.121","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"2023_CR169","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/0271678X156179540271678X15617954","volume":"36","author":"AA Phillips","year":"2016","unstructured":"Phillips AA, Chan FH, Zheng MM, Krassioukov AV, Ainslie PN (2016) Neurovascular coupling in humans: physiology, methodological advances and clinical implications. J Cereb Blood Flow Metab 36(4):647\u2013664. https:\/\/doi.org\/10.1177\/0271678X156179540271678X15617954","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2023_CR170","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1152\/jn.00270.2010jn.00270.2010","volume":"104","author":"B Li","year":"2010","unstructured":"Li B, Freeman RD (2010) Neurometabolic coupling in the lateral geniculate nucleus changes with extended age. J Neurophysiol 104(1):414\u2013425. https:\/\/doi.org\/10.1152\/jn.00270.2010jn.00270.2010","journal-title":"J Neurophysiol"},{"issue":"3","key":"2023_CR171","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","volume":"68","author":"RD Bell","year":"2010","unstructured":"Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68(3):409\u2013427. https:\/\/doi.org\/10.1016\/j.neuron.2010.09.043","journal-title":"Neuron"},{"issue":"2","key":"2023_CR172","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D'Orazio LM, Pachicano M, Sepehrband F, Nelson AR et al (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25(2):270\u2013276. https:\/\/doi.org\/10.1038\/s41591-018-0297-y","journal-title":"Nat Med"},{"issue":"5","key":"2023_CR173","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/jnc.14271","volume":"144","author":"Y Hase","year":"2018","unstructured":"Hase Y, Horsburgh K, Ihara M, Kalaria RN (2018) White matter degeneration in vascular and other ageing-related dementias. J Neurochem 144(5):617\u2013633. https:\/\/doi.org\/10.1111\/jnc.14271","journal-title":"J Neurochem"},{"issue":"3","key":"2023_CR174","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nm.4482","volume":"24","author":"A Montagne","year":"2018","unstructured":"Montagne A, Nikolakopoulou AM, Zhao Z, Sagare AP, Si G, Lazic D, Barnes SR, Daianu M et al (2018) Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Nat Med 24(3):326\u2013337. https:\/\/doi.org\/10.1038\/nm.4482","journal-title":"Nat Med"},{"issue":"1","key":"2023_CR175","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12868-018-0465-5","volume":"19","author":"O Shabir","year":"2018","unstructured":"Shabir O, Berwick J, Francis SE (2018) Neurovascular dysfunction in vascular dementia, Alzheimer\u2019s and atherosclerosis. BMC Neurosci 19(1):62. https:\/\/doi.org\/10.1186\/s12868-018-0465-5","journal-title":"BMC Neurosci"},{"issue":"1","key":"2023_CR176","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","volume":"13","author":"Q Ma","year":"2018","unstructured":"Ma Q, Zhao Z, Sagare AP, Wu Y, Wang M, Owens NC, Verghese PB, Herz J et al (2018) Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-beta42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener 13(1):57. https:\/\/doi.org\/10.1186\/s13024-018-0286-0","journal-title":"Mol Neurodegener"},{"key":"2023_CR177","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y) 4:575\u2013590. https:\/\/doi.org\/10.1016\/j.trci.2018.06.014","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"2023_CR178","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/svn-2016-000021svn-2016-000021","volume":"1","author":"G Zhong","year":"2016","unstructured":"Zhong G, Lou M (2016) Multimodal imaging findings in normal-appearing white matter of leucoaraiosis: a review. Stroke Vasc Neurol 1(2):59\u201363. https:\/\/doi.org\/10.1136\/svn-2016-000021svn-2016-000021","journal-title":"Stroke Vasc Neurol"},{"issue":"2","key":"2023_CR179","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/jnnp.2009.172072jnnp.2009.172072","volume":"81","author":"R Topakian","year":"2010","unstructured":"Topakian R, Barrick TR, Howe FA, Markus HS (2010) Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 81(2):192\u2013197. https:\/\/doi.org\/10.1136\/jnnp.2009.172072jnnp.2009.172072","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"2023_CR180","doi-asserted-by":"publisher","first-page":"534","DOI":"10.4103\/1673-5374.180372NRR-11-534","volume":"11","author":"S Balusu","year":"2016","unstructured":"Balusu S, Brkic M, Libert C, Vandenbroucke RE (2016) The choroid plexus-cerebrospinal fluid interface in Alzheimer\u2019s disease: more than just a barrier. Neural Regen Res 11(4):534\u2013537. https:\/\/doi.org\/10.4103\/1673-5374.180372NRR-11-534","journal-title":"Neural Regen Res"},{"issue":"4","key":"2023_CR181","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.exger.2008.12.004","volume":"44","author":"RL Chen","year":"2009","unstructured":"Chen RL, Kassem NA, Redzic ZB, Chen CP, Segal MB, Preston JE (2009) Age-related changes in choroid plexus and blood-cerebrospinal fluid barrier function in the sheep. Exp Gerontol 44(4):289\u2013296. https:\/\/doi.org\/10.1016\/j.exger.2008.12.004","journal-title":"Exp Gerontol"},{"key":"2023_CR182","doi-asserted-by":"publisher","unstructured":"Boese AC, Hamblin MH, Lee JP (2019) Neural stem cell therapy for neurovascular injury in Alzheimer\u2019s disease. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113112","DOI":"10.1016\/j.expneurol.2019.113112"},{"issue":"1","key":"2023_CR183","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0271678X16679420","volume":"37","author":"F Erdo","year":"2017","unstructured":"Erdo F, Denes L, de Lange E (2017) Age-associated physiological and pathological changes at the blood-brain barrier: a review. J Cereb Blood Flow Metab 37(1):4\u201324. https:\/\/doi.org\/10.1177\/0271678X16679420","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"2023_CR184","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"RE Tanzi","year":"2005","unstructured":"Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective. Cell 120(4):545\u2013555. https:\/\/doi.org\/10.1016\/j.cell.2005.02.008","journal-title":"Cell"},{"issue":"10","key":"2023_CR185","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1523\/JNEUROSCI.4391-04.2005","volume":"25","author":"DM Walsh","year":"2005","unstructured":"Walsh DM, Townsend M, Podlisny MB, Shankar GM, Fadeeva JV, El Agnaf O, Hartley DM, Selkoe DJ (2005) Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. J Neurosci 25(10):2455\u20132462. https:\/\/doi.org\/10.1523\/JNEUROSCI.4391-04.2005","journal-title":"J Neurosci"},{"issue":"10","key":"2023_CR186","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41583-018-0054-8","volume":"19","author":"J Gotz","year":"2018","unstructured":"Gotz J, Bodea LG, Goedert M (2018) Rodent models for Alzheimer disease. Nat Rev Neurosci 19(10):583\u2013598. https:\/\/doi.org\/10.1038\/s41583-018-0054-8","journal-title":"Nat Rev Neurosci"},{"issue":"15\u201317","key":"2023_CR187","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1097\/00001756-199611040-00040","volume":"7","author":"JR Ghilardi","year":"1996","unstructured":"Ghilardi JR, Catton M, Stimson ER, Rogers S, Walker LC, Maggio JE, Mantyh PW (1996) Intra-arterial infusion of [125I]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo. Neuroreport 7(15\u201317):2607\u20132611","journal-title":"Neuroreport"},{"issue":"2\u20133","key":"2023_CR188","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0304-3940(96)12462-9","volume":"206","author":"CL Martel","year":"1996","unstructured":"Martel CL, Mackic JB, McComb JG, Ghiso J, Zlokovic BV (1996) Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer\u2019s amyloid beta in guinea pigs. Neurosci Lett 206(2\u20133):157\u2013160","journal-title":"Neurosci Lett"},{"issue":"10","key":"2023_CR189","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1007\/s12035-019-1594-2","volume":"56","author":"B Van Gool","year":"2019","unstructured":"Van Gool B, Storck SE, Reekmans SM, Lechat B, Gordts P, Pradier L, Pietrzik CU, Roebroek AJM (2019) LRP1 Has a predominant role in production over clearance of abeta in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol 56(10):7234\u20137245. https:\/\/doi.org\/10.1007\/s12035-019-1594-2","journal-title":"Mol Neurobiol"},{"issue":"9","key":"2023_CR190","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nm1635","volume":"13","author":"A Sagare","year":"2007","unstructured":"Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R, Marky A, Lenting PJ et al (2007) Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med 13(9):1029\u20131031. https:\/\/doi.org\/10.1038\/nm1635","journal-title":"Nat Med"},{"issue":"5563","key":"2023_CR191","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1126\/science.1067568295\/5563\/2264","volume":"295","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM (2002) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer\u2019s disease. Science 295(5563):2264\u20132267. https:\/\/doi.org\/10.1126\/science.1067568295\/5563\/2264","journal-title":"Science"},{"issue":"2","key":"2023_CR192","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0002-9440(10)61715-4","volume":"159","author":"EM Sigurdsson","year":"2001","unstructured":"Sigurdsson EM, Scholtzova H, Mehta PD, Frangione B, Wisniewski T (2001) Immunization with a nontoxic\/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer\u2019s disease-associated pathology in transgenic mice. Am J Pathol 159(2):439\u2013447","journal-title":"Am J Pathol"},{"issue":"10","key":"2023_CR193","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/sj.mp.4001509","volume":"9","author":"Q Zha","year":"2004","unstructured":"Zha Q, Ruan Y, Hartmann T, Beyreuther K, Zhang D (2004) GM1 ganglioside regulates the proteolysis of amyloid precursor protein. Mol Psychiatry 9(10):946\u2013952. https:\/\/doi.org\/10.1038\/sj.mp.4001509","journal-title":"Mol Psychiatry"},{"issue":"16","key":"2023_CR194","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1073\/pnas.09003451060900345106","volume":"106","author":"EM Reiman","year":"2009","unstructured":"Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J et al (2009) Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 106(16):6820\u20136825. https:\/\/doi.org\/10.1073\/pnas.09003451060900345106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2023_CR195","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1523\/JNEUROSCI.23-01-00029.2003","volume":"23","author":"Y Matsuoka","year":"2003","unstructured":"Matsuoka Y, Saito M, LaFrancois J, Gaynor K, Olm V, Wang L, Casey E, Lu Y et al (2003) Novel therapeutic approach for the treatment of Alzheimer\u2019s disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci 23(1):29\u201333","journal-title":"J Neurosci"},{"issue":"17","key":"2023_CR196","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1021\/acs.jmedchem.7b00058","volume":"60","author":"S Bongarzone","year":"2017","unstructured":"Bongarzone S, Savickas V, Luzi F, Gee AD (2017) Targeting the receptor for advanced glycation endproducts (RAGE): a medicinal chemistry perspective. J Med Chem 60(17):7213\u20137232. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00058","journal-title":"J Med Chem"},{"issue":"7","key":"2023_CR197","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L et al (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9(7):907\u2013913. https:\/\/doi.org\/10.1038\/nm890nm890","journal-title":"Nat Med"},{"issue":"4","key":"2023_CR198","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1172\/JCI2029","volume":"102","author":"JB Mackic","year":"1998","unstructured":"Mackic JB, Stins M, McComb JG, Calero M, Ghiso J, Kim KS, Yan SD, Stern D et al (1998) Human blood-brain barrier receptors for Alzheimer\u2019s amyloid-beta 1\u201340. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest 102(4):734\u2013743. https:\/\/doi.org\/10.1172\/JCI2029","journal-title":"J Clin Invest"},{"issue":"6","key":"2023_CR199","doi-asserted-by":"publisher","first-page":"C1772","DOI":"10.1152\/ajpcell.2000.279.6.C1772","volume":"279","author":"R Giri","year":"2000","unstructured":"Giri R, Shen Y, Stins M, Du Yan S, Schmidt AM, Stern D, Kim KS, Zlokovic B et al (2000) beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol 279(6):C1772\u2013C1781. https:\/\/doi.org\/10.1152\/ajpcell.2000.279.6.C1772","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6593","key":"2023_CR200","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L et al (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease. Nature 382(6593):685\u2013691. https:\/\/doi.org\/10.1038\/382685a0","journal-title":"Nature"},{"issue":"5","key":"2023_CR201","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","volume":"115","author":"BV Zlokovic","year":"2010","unstructured":"Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA (2010) Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer\u2019s amyloid beta-peptide elimination from the brain. J Neurochem 115(5):1077\u20131089. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07002.x","journal-title":"J Neurochem"},{"issue":"2\u20133","key":"2023_CR202","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12017-017-8446-x","volume":"19","author":"H Hou","year":"2017","unstructured":"Hou H, Habib A, Zi D, Tian K, Tian J, Giunta B, Sawmiller D, Tan J (2017) Low-density lipoprotein receptor-related protein-1 (LRP1) C4408R mutant promotes amyloid precursor protein (APP) alpha-cleavage in vitro. Neuromolecular Med 19(2\u20133):300\u2013308. https:\/\/doi.org\/10.1007\/s12017-017-8446-x","journal-title":"Neuromolecular Med"},{"issue":"19","key":"2023_CR203","doi-asserted-by":"publisher","first-page":"20296","DOI":"10.1074\/jbc.M312946200M312946200","volume":"279","author":"J Davis","year":"2004","unstructured":"Davis J, Xu F, Deane R, Romanov G, Previti ML, Zeigler K, Zlokovic BV, Van Nostrand WE (2004) Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch\/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 279(19):20296\u201320306. https:\/\/doi.org\/10.1074\/jbc.M312946200M312946200","journal-title":"J Biol Chem"},{"issue":"5","key":"2023_CR204","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-018-1834-y","volume":"135","author":"M Hecht","year":"2018","unstructured":"Hecht M, Kramer LM, von Arnim CAF, Otto M, Thal DR (2018) Capillary cerebral amyloid angiopathy in Alzheimer\u2019s disease: association with allocortical\/hippocampal microinfarcts and cognitive decline. Acta Neuropathol 135(5):681\u2013694. https:\/\/doi.org\/10.1007\/s00401-018-1834-y","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2023_CR205","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"DR Thal","year":"2008","unstructured":"Thal DR, Griffin WS, de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease. Acta Neuropathol 115(6):599\u2013609. https:\/\/doi.org\/10.1007\/s00401-008-0366-2","journal-title":"Acta Neuropathol"},{"issue":"17","key":"2023_CR206","doi-asserted-by":"publisher","first-page":"9735","DOI":"10.1073\/pnas.97.17.9735","volume":"97","author":"K Niwa","year":"2000","unstructured":"Niwa K, Younkin L, Ebeling C, Turner SK, Westaway D, Younkin S, Ashe KH, Carlson GA et al (2000) Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A 97(17):9735\u20139740. https:\/\/doi.org\/10.1073\/pnas.97.17.9735","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2023_CR207","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI124853124853","volume":"129","author":"M Tachibana","year":"2019","unstructured":"Tachibana M, Holm ML, Liu CC, Shinohara M, Aikawa T, Oue H, Yamazaki Y, Martens YA et al (2019) APOE4-mediated amyloid-beta pathology depends on its neuronal receptor LRP1. J Clin Invest 129(3):1272\u20131277. https:\/\/doi.org\/10.1172\/JCI124853124853","journal-title":"J Clin Invest"},{"issue":"12","key":"2023_CR208","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI3666336663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV (2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118(12):4002\u20134013. https:\/\/doi.org\/10.1172\/JCI3666336663","journal-title":"J Clin Invest"},{"issue":"2","key":"2023_CR209","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","volume":"41","author":"RB DeMattos","year":"2004","unstructured":"DeMattos RB, Cirrito JR, Parsadanian M, May PC, O'Dell MA, Taylor JW, Harmony JA, Aronow BJ et al (2004) ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41(2):193\u2013202","journal-title":"Neuron"},{"key":"2023_CR210","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbi.2018.07.017","volume":"73","author":"SE Storck","year":"2018","unstructured":"Storck SE, Hartz AMS, Bernard J, Wolf A, Kachlmeier A, Mahringer A, Weggen S, Pahnke J et al (2018) The concerted amyloid-beta clearance of LRP1 and ABCB1\/P-gp across the blood-brain barrier is linked by PICALM. Brain Behav Immun 73:21\u201333. https:\/\/doi.org\/10.1016\/j.bbi.2018.07.017","journal-title":"Brain Behav Immun"},{"issue":"11","key":"2023_CR211","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.freeradbiomed.2010.09.013","volume":"49","author":"JB Owen","year":"2010","unstructured":"Owen JB, Sultana R, Aluise CD, Erickson MA, Price TO, Bu G, Banks WA, Butterfield DA (2010) Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Abeta accumulation in AD brain. Free Radic Biol Med 49(11):1798\u20131803. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.09.013","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"2023_CR212","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neuro.2010.05.004","volume":"31","author":"M Behl","year":"2010","unstructured":"Behl M, Zhang Y, Shi Y, Cheng J, Du Y, Zheng W (2010) Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C. Neurotoxicology 31(5):524\u2013532. https:\/\/doi.org\/10.1016\/j.neuro.2010.05.004","journal-title":"Neurotoxicology"},{"issue":"2","key":"2023_CR213","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0304-3940(03)00898-X","volume":"350","author":"H Kanemitsu","year":"2003","unstructured":"Kanemitsu H, Tomiyama T, Mori H (2003) Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci Lett 350(2):113\u2013116","journal-title":"Neurosci Lett"},{"issue":"5521","key":"2023_CR214","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.1059946292\/5521\/1550","volume":"292","author":"N Iwata","year":"2001","unstructured":"Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E et al (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292(5521):1550\u20131552. https:\/\/doi.org\/10.1126\/science.1059946292\/5521\/1550","journal-title":"Science"},{"issue":"49","key":"2023_CR215","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, Safavi A et al (1998) Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273(49):32730\u201332738","journal-title":"J Biol Chem"},{"issue":"26","key":"2023_CR216","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1523\/JNEUROSCI.23-26-08867.2003","volume":"23","author":"JP Melchor","year":"2003","unstructured":"Melchor JP, Pawlak R, Strickland S (2003) The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J Neurosci 23(26):8867\u20138871","journal-title":"J Neurosci"},{"issue":"43","key":"2023_CR217","doi-asserted-by":"publisher","first-page":"10939","DOI":"10.1523\/JNEUROSCI.2085-06.2006","volume":"26","author":"KJ Yin","year":"2006","unstructured":"Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, Bateman R, Song H et al (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J Neurosci 26(43):10939\u201310948. https:\/\/doi.org\/10.1523\/JNEUROSCI.2085-06.2006","journal-title":"J Neurosci"},{"issue":"1","key":"2023_CR218","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40478-019-0728-0","volume":"7","author":"AJ Smith","year":"2019","unstructured":"Smith AJ, Duan T, Verkman AS (2019) Aquaporin-4 reduces neuropathology in a mouse model of Alzheimer\u2019s disease by remodeling peri-plaque astrocyte structure. Acta Neuropathol Commun 7(1):74. https:\/\/doi.org\/10.1186\/s40478-019-0728-0","journal-title":"Acta Neuropathol Commun"},{"key":"2023_CR219","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-015-0056-1","volume":"10","author":"Z Xu","year":"2015","unstructured":"Xu Z, Xiao N, Chen Y, Huang H, Marshall C, Gao J, Cai Z, Wu T et al (2015) Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain Abeta accumulation and memory deficits. Mol Neurodegener 10:58. https:\/\/doi.org\/10.1186\/s13024-015-0056-1","journal-title":"Mol Neurodegener"},{"issue":"22","key":"2023_CR220","doi-asserted-by":"publisher","first-page":"15493","DOI":"10.1074\/jbc.274.22.15493","volume":"274","author":"VD Bianca","year":"1999","unstructured":"Bianca VD, Dusi S, Bianchini E, Dal Pra I, Rossi F (1999) beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer\u2019s disease. J Biol Chem 274(22):15493\u201315499","journal-title":"J Biol Chem"},{"issue":"5","key":"2023_CR221","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.bbadis.2015.11.010","volume":"1862","author":"V Galvan","year":"2016","unstructured":"Galvan V, Hart MJ (2016) Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer\u2019s disease. Biochim Biophys Acta 1862(5):992\u20131007. https:\/\/doi.org\/10.1016\/j.bbadis.2015.11.010","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2023_CR222","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0022-2828(03)00110-X","volume":"35","author":"JM Miano","year":"2003","unstructured":"Miano JM (2003) Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 35(6):577\u2013593","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"2023_CR223","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0092-8674(01)00404-4","volume":"105","author":"D Wang","year":"2001","unstructured":"Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN (2001) Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105(7):851\u2013862","journal-title":"Cell"},{"issue":"1","key":"2023_CR224","doi-asserted-by":"publisher","first-page":"17490","DOI":"10.1038\/s41598-017-17718-y","volume":"7","author":"M Gejl","year":"2017","unstructured":"Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A (2017) Blood-brain glucose transfer in Alzheimer\u2019s disease: effect of GLP-1 analog treatment. Sci Rep 7(1):17490. https:\/\/doi.org\/10.1038\/s41598-017-17718-y","journal-title":"Sci Rep"},{"issue":"10","key":"2023_CR225","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1097\/RLU.000000000000054700003072-201410000-00026","volume":"39","author":"C Marcus","year":"2014","unstructured":"Marcus C, Mena E, Subramaniam RM (2014) Brain PET in the diagnosis of Alzheimer\u2019s disease. Clin Nucl Med 39(10):e413\u2013e422; quiz e423\u2013416. https:\/\/doi.org\/10.1097\/RLU.000000000000054700003072-201410000-00026","journal-title":"Clin Nucl Med"},{"issue":"6","key":"2023_CR226","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/archpsyc.1989.01810060047008","volume":"46","author":"GW Small","year":"1989","unstructured":"Small GW, Kuhl DE, Riege WH, Fujikawa DG, Ashford JW, Metter EJ, Mazziotta JC (1989) Cerebral glucose metabolic patterns in Alzheimer\u2019s disease. Effect of gender and age at dementia onset. Arch Gen Psychiatry 46(6):527\u2013532","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"2023_CR227","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","volume":"30","author":"A Drzezga","year":"2003","unstructured":"Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer\u2019s disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30(8):1104\u20131113. https:\/\/doi.org\/10.1007\/s00259-003-1194-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2023_CR228","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF02988444","volume":"17","author":"K Herholz","year":"2003","unstructured":"Herholz K (2003) PET studies in dementia. Ann Nucl Med 17(2):79\u201389","journal-title":"Ann Nucl Med"},{"issue":"10","key":"2023_CR229","first-page":"1633","volume":"46","author":"WP Chen","year":"2005","unstructured":"Chen WP, Matsunari I, Noda A, Yanase D, Yajima K, Takeda N, Yamada M, Minoshima S et al (2005) Rapid scanning protocol for brain (18)F-FDG PET: a validation study. J Nucl Med 46(10):1633\u20131641","journal-title":"J Nucl Med"},{"issue":"6570","key":"2023_CR230","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/380168a0","volume":"380","author":"T Thomas","year":"1996","unstructured":"Thomas T, Thomas G, McLendon C, Sutton T, Mullan M (1996) beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380(6570):168\u2013171. https:\/\/doi.org\/10.1038\/380168a0","journal-title":"Nature"},{"key":"2023_CR231","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnagi.2019.00047","volume":"11","author":"Z Amtul","year":"2019","unstructured":"Amtul Z, Yang J, Lee TY, Cechetto DF (2019) Pathological changes in microvascular morphology, density, size and responses following comorbid cerebral injury. Front Aging Neurosci 11:47. https:\/\/doi.org\/10.3389\/fnagi.2019.00047","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"2023_CR232","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1046\/j.1471-4159.1998.70052212.x","volume":"70","author":"MA Smith","year":"1998","unstructured":"Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Siedlak SL, Tabaton M, Perry G (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70(5):2212\u20132215","journal-title":"J Neurochem"},{"issue":"5","key":"2023_CR233","doi-asserted-by":"publisher","first-page":"568","DOI":"10.21037\/cdt.2018.07.01cdt-08-05-568","volume":"8","author":"M Hamilos","year":"2018","unstructured":"Hamilos M, Petousis S, Parthenakis F (2018) Interaction between platelets and endothelium: from pathophysiology to new therapeutic options. Cardiovasc Diagn Ther 8(5):568\u2013580. https:\/\/doi.org\/10.21037\/cdt.2018.07.01cdt-08-05-568","journal-title":"Cardiovasc Diagn Ther"},{"issue":"1","key":"2023_CR234","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0002-9440(10)64354-4","volume":"160","author":"IS Coraci","year":"2002","unstructured":"Coraci IS, Husemann J, Berman JW, Hulette C, Dufour JH, Campanella GK, Luster AD, Silverstein SC et al (2002) CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer\u2019s disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am J Pathol 160(1):101\u2013112","journal-title":"Am J Pathol"},{"issue":"1","key":"2023_CR235","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1096\/fj.11-0102ufm25\/1\/5","volume":"25","author":"VT Marchesi","year":"2011","unstructured":"Marchesi VT (2011) Alzheimer\u2019s dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J 25(1):5\u201313. https:\/\/doi.org\/10.1096\/fj.11-0102ufm25\/1\/5","journal-title":"FASEB J"},{"key":"2023_CR236","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fnagi.2019.00146","volume":"11","author":"GA Edwards Iii","year":"2019","unstructured":"Edwards Iii GA, Gamez N, Escobedo G Jr, Calderon O, Moreno-Gonzalez I (2019) Modifiable risk factors for Alzheimer\u2019s disease. Front Aging Neurosci 11:146. https:\/\/doi.org\/10.3389\/fnagi.2019.00146","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2023_CR237","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.arr.2010.04.002","volume":"9","author":"JC de la Torre","year":"2010","unstructured":"de la Torre JC (2010) Vascular risk factor detection and control may prevent Alzheimer\u2019s disease. Ageing Res Rev 9(3):218\u2013225. https:\/\/doi.org\/10.1016\/j.arr.2010.04.002","journal-title":"Ageing Res Rev"},{"issue":"4","key":"2023_CR238","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archneur.64.4.570","volume":"64","author":"JA Luchsinger","year":"2007","unstructured":"Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol 64(4):570\u2013575. https:\/\/doi.org\/10.1001\/archneur.64.4.570","journal-title":"Arch Neurol"},{"issue":"6","key":"2023_CR239","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cmet.2008.03.010","volume":"7","author":"C Iadecola","year":"2008","unstructured":"Iadecola C, Davisson RL (2008) Hypertension and cerebrovascular dysfunction. Cell Metab 7(6):476\u2013484. https:\/\/doi.org\/10.1016\/j.cmet.2008.03.010","journal-title":"Cell Metab"},{"issue":"14","key":"2023_CR240","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1212\/01.wnl.0000306313.89165.ef01.wnl.0000306313.89165.ef","volume":"71","author":"RA Whitmer","year":"2008","unstructured":"Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71(14):1057\u20131064. https:\/\/doi.org\/10.1212\/01.wnl.0000306313.89165.ef01.wnl.0000306313.89165.ef","journal-title":"Neurology"},{"issue":"8","key":"2023_CR241","first-page":"504","volume":"40","author":"G DeMaagd","year":"2015","unstructured":"DeMaagd G, Philip A (2015) Parkinson\u2019s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P T 40(8):504\u2013532","journal-title":"P T"},{"issue":"19","key":"2023_CR242","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ (2018) Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J 285(19):3657\u20133668. https:\/\/doi.org\/10.1111\/febs.14607","journal-title":"FEBS J"},{"issue":"2","key":"2023_CR243","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3233\/JAD-150610","volume":"51","author":"A Pilotto","year":"2016","unstructured":"Pilotto A, Turrone R, Liepelt-Scarfone I, Bianchi M, Poli L, Borroni B, Alberici A, Premi E et al (2016) Vascular risk factors and cognition in Parkinson\u2019s disease. J Alzheimers Dis 51(2):563\u2013570. https:\/\/doi.org\/10.3233\/JAD-150610","journal-title":"J Alzheimers Dis"},{"key":"2023_CR244","doi-asserted-by":"publisher","first-page":"116578","DOI":"10.1016\/j.jns.2019.116578","volume":"408","author":"DS Gutteridge","year":"2020","unstructured":"Gutteridge DS, Saredakis D, Badcock NA, Collins-Praino LE, Keage HAD (2020) Cerebrovascular function during cognition in Parkinson\u2019s disease: a functional transcranial Doppler sonography study. J Neurol Sci 408:116578. https:\/\/doi.org\/10.1016\/j.jns.2019.116578","journal-title":"J Neurol Sci"},{"issue":"5","key":"2023_CR245","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","volume":"35","author":"MT Gray","year":"2015","unstructured":"Gray MT, Woulfe JM (2015) Striatal blood-brain barrier permeability in Parkinson\u2019s disease. J Cereb Blood Flow Metab 35(5):747\u2013750. https:\/\/doi.org\/10.1038\/jcbfm.2015.32","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"2023_CR246","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1212\/01.wnl.0000068008.78394.2c","volume":"60","author":"JH Bower","year":"2003","unstructured":"Bower JH, Maraganore DM, Peterson BJ, McDonnell SK, Ahlskog JE, Rocca WA (2003) Head trauma preceding PD: a case-control study. Neurology 60(10):1610\u20131615. https:\/\/doi.org\/10.1212\/01.wnl.0000068008.78394.2c","journal-title":"Neurology"},{"issue":"1","key":"2023_CR247","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000048607","volume":"21","author":"T Foltynie","year":"2002","unstructured":"Foltynie T, Barker R, Brayne C (2002) Vascular parkinsonism: a review of the precision and frequency of the diagnosis. Neuroepidemiology 21(1):1\u20137. https:\/\/doi.org\/10.1159\/000048607","journal-title":"Neuroepidemiology"},{"key":"2023_CR248","doi-asserted-by":"publisher","unstructured":"Haddad F, Sawalha M, Khawaja Y, Najjar A, Karaman R (2017) Dopamine and levodopa prodrugs for the treatment of Parkinson\u2019s disease. Molecules 23(1). https:\/\/doi.org\/10.3390\/molecules23010040","DOI":"10.3390\/molecules23010040"},{"issue":"9516","key":"2023_CR249","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0140-6736(06)68350-5","volume":"367","author":"B Winblad","year":"2006","unstructured":"Winblad B, Kilander L, Eriksson S, Minthon L, Batsman S, Wetterholm AL, Jansson-Blixt C, Haglund A (2006) Donepezil in patients with severe Alzheimer\u2019s disease: double-blind, parallel-group, placebo-controlled study. Lancet 367(9516):1057\u20131065. https:\/\/doi.org\/10.1016\/S0140-6736(06)68350-5","journal-title":"Lancet"},{"key":"2023_CR250","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jns.2016.07.041","volume":"368","author":"SS Ahmed","year":"2016","unstructured":"Ahmed SS, Husain RS, Kumar S, Ramakrishnan V (2016) Association between MDR1 gene polymorphisms and Parkinson\u2019s disease in Asian and Caucasian populations: a meta-analysis. J Neurol Sci 368:255\u2013262. https:\/\/doi.org\/10.1016\/j.jns.2016.07.041","journal-title":"J Neurol Sci"},{"issue":"9","key":"2023_CR251","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.neurobiolaging.2005.06.015","volume":"27","author":"E Carro","year":"2006","unstructured":"Carro E, Trejo JL, Gerber A, Loetscher H, Torrado J, Metzger F, Torres-Aleman I (2006) Therapeutic actions of insulin-like growth factor I on APP\/PS2 mice with severe brain amyloidosis. Neurobiol Aging 27(9):1250\u20131257. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.06.015","journal-title":"Neurobiol Aging"},{"issue":"21","key":"2023_CR252","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1016\/j.biomaterials.2010.03.042","volume":"31","author":"C Spuch","year":"2010","unstructured":"Spuch C, Antequera D, Portero A, Orive G, Hernandez RM, Molina JA, Bermejo-Pareja F, Pedraz JL et al (2010) The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer\u2019s disease. Biomaterials 31(21):5608\u20135618. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.03.042","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"2023_CR253","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.09.003","volume":"216","author":"YX Chao","year":"2009","unstructured":"Chao YX, He BP, Tay SS (2009) Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson\u2019s disease. J Neuroimmunol 216(1\u20132):39\u201350. https:\/\/doi.org\/10.1016\/j.jneuroim.2009.09.003","journal-title":"J Neuroimmunol"},{"key":"2023_CR254","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fncel.2019.00412","volume":"13","author":"D Manrique-Castano","year":"2019","unstructured":"Manrique-Castano D, Sardari M, Silva de Carvalho T, Doeppner TR, Popa-Wagner A, Kleinschnitz C, Chan A, Hermann DM (2019) Deactivation of ATP-binding cassette transporters ABCB1 and ABCC1 does not influence post-ischemic neurological deficits, secondary neurodegeneration and neurogenesis, but induces subtle microglial morphological changes. Front Cell Neurosci 13:412. https:\/\/doi.org\/10.3389\/fncel.2019.00412","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"2023_CR255","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","volume":"30","author":"AL Bartels","year":"2009","unstructured":"Bartels AL, Kortekaas R, Bart J, Willemsen AT, de Klerk OL, de Vries JJ, van Oostrom JC, Leenders KL (2009) Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging 30(11):1818\u20131824. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.02.002","journal-title":"Neurobiol Aging"},{"key":"2023_CR256","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2016.01.003","volume":"317","author":"H Sun","year":"2016","unstructured":"Sun H, Liang R, Yang B, Zhou Y, Liu M, Fang F, Ding J, Fan Y et al (2016) Aquaporin-4 mediates communication between astrocyte and microglia: implications of neuroinflammation in experimental Parkinson\u2019s disease. Neuroscience 317:65\u201375. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.003","journal-title":"Neuroscience"},{"issue":"10","key":"2023_CR257","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1073\/pnas.1818415116","volume":"116","author":"J Mitra","year":"2019","unstructured":"Mitra J, Guerrero EN, Hegde PM, Liachko NF, Wang H, Vasquez V, Gao J, Pandey A et al (2019) Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc Natl Acad Sci U S A 116(10):4696\u20134705. https:\/\/doi.org\/10.1073\/pnas.1818415116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2023_CR258","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","volume":"125","author":"AM Blokhuis","year":"2013","unstructured":"Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ (2013) Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 125(6):777\u2013794. https:\/\/doi.org\/10.1007\/s00401-013-1125-6","journal-title":"Acta Neuropathol"},{"issue":"7","key":"2023_CR259","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/arclin\/acx086","volume":"32","author":"JS Snowden","year":"2017","unstructured":"Snowden JS (2017) The neuropsychology of Huntington\u2019s disease. Arch Clin Neuropsychol 32(7):876\u2013887. https:\/\/doi.org\/10.1093\/arclin\/acx086","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"2023_CR260","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334. https:\/\/doi.org\/10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"issue":"1","key":"2023_CR261","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10(1):83\u201398. https:\/\/doi.org\/10.1016\/S1474-4422(10)70245-3","journal-title":"Lancet Neurol"},{"key":"2023_CR262","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-71779-1_1","volume":"1049","author":"R Ghosh","year":"2018","unstructured":"Ghosh R, Tabrizi SJ (2018) Clinical features of Huntington\u2019s disease. Adv Exp Med Biol 1049:1\u201328. https:\/\/doi.org\/10.1007\/978-3-319-71779-1_1","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"2023_CR263","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.24428","volume":"78","author":"HY Hsiao","year":"2015","unstructured":"Hsiao HY, Chen YC, Huang CH, Chen CC, Hsu YH, Chen HM, Chiu FL, Kuo HC et al (2015) Aberrant astrocytes impair vascular reactivity in Huntington disease. Ann Neurol 78(2):178\u2013192. https:\/\/doi.org\/10.1002\/ana.24428","journal-title":"Ann Neurol"},{"issue":"21","key":"2023_CR264","doi-asserted-by":"publisher","first-page":"15154","DOI":"10.1074\/jbc.M112.439570","volume":"288","author":"AP Sagare","year":"2013","unstructured":"Sagare AP, Bell RD, Srivastava A, Sengillo JD, Singh I, Nishida Y, Chow N, Zlokovic BV (2013) A lipoprotein receptor cluster IV mutant preferentially binds amyloid-beta and regulates its clearance from the mouse brain. J Biol Chem 288(21):15154\u201315166. https:\/\/doi.org\/10.1074\/jbc.M112.439570","journal-title":"J Biol Chem"},{"issue":"3","key":"2023_CR265","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/JAD-2009-1074","volume":"17","author":"LB Jaeger","year":"2009","unstructured":"Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-DeMotta MA, Lynch JL, Robinson SM et al (2009) Testing the neurovascular hypothesis of Alzheimer\u2019s disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J Alzheimers Dis 17(3):553\u2013570. https:\/\/doi.org\/10.3233\/JAD-2009-1074","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2023_CR266","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1023\/a:1004003008683","volume":"32","author":"A Gschanes","year":"2000","unstructured":"Gschanes A, Boado R, Sametz W, Windisch M (2000) The drug cerebrolysin and its peptide fraction E021 increase the abundance of the blood-brain barrier GLUT1 glucose transporter in brains of young and old rats. Histochem J 32(2):71\u201377. https:\/\/doi.org\/10.1023\/a:1004003008683","journal-title":"Histochem J"},{"issue":"4","key":"2023_CR267","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1172\/JCI58642","volume":"122","author":"R Deane","year":"2012","unstructured":"Deane R, Singh I, Sagare AP, Bell RD, Ross NT, LaRue B, Love R, Perry S et al (2012) A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 122(4):1377\u20131392. https:\/\/doi.org\/10.1172\/JCI58642","journal-title":"J Clin Invest"},{"key":"2023_CR268","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1038\/srep02053","volume":"3","author":"P Religa","year":"2013","unstructured":"Religa P, Cao R, Religa D, Xue Y, Bogdanovic N, Westaway D, Marti HH, Winblad B et al (2013) VEGF significantly restores impaired memory behavior in Alzheimer\u2019s mice by improvement of vascular survival. Sci Rep 3:2053. https:\/\/doi.org\/10.1038\/srep02053","journal-title":"Sci Rep"},{"issue":"3","key":"2023_CR269","doi-asserted-by":"publisher","first-page":"e0213508","DOI":"10.1371\/journal.pone.0213508","volume":"14","author":"F Girolamo","year":"2019","unstructured":"Girolamo F, Errede M, Longo G, Annese T, Alias C, Ferrara G, Morando S, Trojano M et al (2019) Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice. PLoS One 14(3):e0213508. https:\/\/doi.org\/10.1371\/journal.pone.0213508","journal-title":"PLoS One"},{"issue":"7323","key":"2023_CR270","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J et al (2010) Pericytes regulate the blood-brain barrier. Nature 468(7323):557\u2013561. https:\/\/doi.org\/10.1038\/nature09522","journal-title":"Nature"},{"key":"2023_CR271","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.neuroscience.2015.10.006","volume":"310","author":"HF Zhao","year":"2015","unstructured":"Zhao HF, Li N, Wang Q, Cheng XJ, Li XM, Liu TT (2015) Resveratrol decreases the insoluble Abeta1-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats. Neuroscience 310:641\u2013649. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.10.006","journal-title":"Neuroscience"},{"issue":"45","key":"2023_CR272","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.1074\/jbc.M508246200","volume":"280","author":"P Marambaud","year":"2005","unstructured":"Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-beta peptides. J Biol Chem 280(45):37377\u201337382. https:\/\/doi.org\/10.1074\/jbc.M508246200","journal-title":"J Biol Chem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02023-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-02023-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02023-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T19:52:03Z","timestamp":1696449123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-02023-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":272,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2023"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02023-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"13 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}